Immunology

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
(4 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 20: Zeile 20:
 
*'''[[Hematology ]]'''
 
*'''[[Hematology ]]'''
 
*'''[[Cytokine_storm,_hemophagocytic_lymphohistiocytosis,_macrophage_activation_syndrome|Cytokine storm ]]'''
 
*'''[[Cytokine_storm,_hemophagocytic_lymphohistiocytosis,_macrophage_activation_syndrome|Cytokine storm ]]'''
*'''[[ ]]'''
+
*'''[[Candidate_Compounds_Covid19 |Immunopharmacology ]]'''
*'''[[ ]]'''
+
*'''[[Diagnosis_(Laboratory) |Clinical Laboratory Dx]]'''
*'''[[ ]]'''
+
  
===Antibody-dependent enhancement===
+
012
{{tp|p=32361326|t=2020. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.|pdf=|usr=008}}
+
{{ttp|p=32504046|t=2020. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.|pdf=|usr=007}}
+
{{ttp|p=32092539|t=2020. Is COVID-19 receiving ADE from other coronaviruses?|pdf=|usr=}}
+
{{tp|p=32268188|t=ä. It is too soon to attribute ADE to COVID-19 |pdf=|usr=}}
+
{{ttp|p=31826992|t=2020. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry |pdf=|usr=}}''antibodies target one serotype of viruses but only subneutralize another, leading to antibody-dependend enhancement of the latter viruses.''
+
{{ttp|p=32317716|t=ä. The potential danger of suboptimal antibody responses in COVID-19 |pdf=|usr=}} ade
+
{{tp|p=32346094|t=ä. COVID-19 vaccine design: the Janus face of immune enhancement |pdf=|usr=}}
+
{{tp|p=32303697|t=ä. Will we see protection or reinfection in COVID-19?|pdf=|usr=}}
+
{{tp|p=32438257|t=2020. SARS-CoV-2 and enhancing antibodies |pdf=|usr=}}
+
{{ttp|p=32408068|t=2020. What about the original antigenic sin of the humans versus SARS-CoV-2?|pdf=|usr=}}''the term «original antigenic sin» (OAS) was coined by T. Francis Jr at the Michigan University in the late 1950s to describe patterns of antibody response to influenza vaccination...''
+
{{tp|p=32436320|t=2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.|pdf=|usr=007}}
+
{{tp|p=32506725|t=2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.|pdf=|usr=007}}
+
{{tp|p=32529906|t=2020. Serological differentiation between COVID-19 and SARS infections.|pdf=|usr=008}}
+
{{tp|p=32380903|t=2020. Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2.|pdf=|usr=008}}
+
{{tp|p=32426212|t=2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.|pdf=|usr=008}}
+
{{tp|p=32526272|t=2020. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.|pdf=|usr=008}}
+
{{tp|p=32590062|t=2020. lall? Due diligence warranted for ADE in COVID-19.|pdf=|usr=010}}
+
{{ttp|p=32595955|t=2020. Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population.|pdf=|usr=011}}
+
{{tp|p=32582200|t=2020. Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.|pdf=|usr=011}}
+
  
  
  
===Herd immunity===
+
head
{{tp|p=32438622|t=2020. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.|pdf=|usr=007}}
+
{{tp|p=32669777|t=2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge von Willebrand Factor (eULVWF) Decorated-Platelet Strings.|pdf=|usr=015}}
{{tp|p=32391855|t=2020. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.|pdf=|usr=007}}
+
{{tp|p=32670298|t=2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.|pdf=|usr=015}}
{{tp|p=32510562|t=2020. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.|pdf=|usr=007}}
+
{{tp|p=32671009|t=2020. Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37.|pdf=|usr=015}}
{{tp|p=32418947|t=2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?|pdf=|usr=007}}
+
{{tp|p=C7255426|t=?. Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2.|pdf=|usr=015}}
{{tp|p=32372779|t=2020. Do you become immune once you have been infected?|pdf=|usr=}}
+
{{tp|p=32658591|t=?. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.|pdf=|usr=015}}
{{tp|p=32433946|t=2020. Herd Immunity: Understanding COVID-19.|pdf=|usr=008}}
+
{{tp|p=C7236793|t=?. Prediction and analysis of key protein structures of 2019-nCoV.|pdf=|usr=015}}
{{tp|p=32509257|t=2020. SARS-CoV-2, "common cold" coronaviruses' cross-reactivity and "herd immunity": The razor of Ockham (1285-1347)?|pdf=|usr=008}}
+
{{tp|p=C7341045|t=2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.|pdf=|usr=015}}
{{tp|p=32397700|t=2020. [Analysis of application of herd immunity as a control strategy for COVID-19].|pdf=|usr=007}}
+
{{tp|p=C7323676|t=?. Coronavirus disease 2019 (COVID-19): cytokine storms hyper-inflammatory phenotypes and acute respiratory distress syndrome.|pdf=|usr=015}}
{{tp|p=32534627|t=2020. Have deaths from COVID-19 in Europe plateaued due to herd immunity?|pdf=|usr=009}}
+
{{tp|p=C7264919|t=?. Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains.|pdf=|usr=015}}
{{tp|p=32434946|t=2020. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.|pdf=|usr=009}}
+
{{tp|p=32668194|t=?. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.|pdf=|usr=015}}
{{tp|p=32585285|t=2020. Herd Immunity and Vaccination of children for COVID19.|pdf=|usr=010}}
+
{{tp|p=32659347|t=2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.|pdf=|usr=015}}
{{tp|p=32576668|t=2020. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2.|pdf=|usr=010}}
+
{{tp|p=C7308782|t=2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.|pdf=|usr=015}}
{{tp|p=32538831|t=2020. Herd immunity or suppression strategy to combat COVID-19.|pdf=|usr=011}}
+
{{tp|p=32683296|t=2020. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.|pdf=|usr=015}}
 +
{{tp|p=32669955|t=2020. A comprehensive investigation of the mRNA and protein level of ACE2 the putative receptor of SARS-CoV-2 in human tissues and blood cells.|pdf=|usr=015}}
 +
{{tp|p=C7274027|t=?. The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development.|pdf=|usr=015}}
 +
{{tp|p=32659712|t=2020. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.|pdf=|usr=015}}
 +
{{tp|p=32707511|t=2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.|pdf=|usr=015}}
 +
{{tp|p=32674001|t=2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis a case series.|pdf=|usr=015}}
 +
{{tp|p=32661206|t=2020. Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human.|pdf=|usr=015}}
 +
{{tp|p=C7358169|t=?. Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?|pdf=|usr=015}}
 +
{{tp|p=C7332243|t=?. Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection.|pdf=|usr=015}}
 +
{{tp|p=C7323226|t=?. Cancer Prevales on Covid?19: To Maintain a High Quality Standard Concerning Diagnosis and Oncological Care Even During a Pandemic.|pdf=|usr=015}}
 +
{{tp|p=C7351386|t=?. Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions.|pdf=|usr=015}}
 +
{{tp|p=C7311326|t=2020. Coronavirus disease 2019?related Kawasaki-like disease in an adult: A case report.|pdf=|usr=015}}
 +
{{tp|p=C7314447|t=?. Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.|pdf=|usr=015}}
 +
{{tp|p=C7296312|t=?. Children at risk: multisystem inflammatory syndrome and COVID-19.|pdf=|usr=015}}
 +
{{tp|p=C7316659|t=?. Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.|pdf=|usr=015}}
 +
{{tp|p=C7275990|t=?. COVID-19?Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.|pdf=|usr=015}}
 +
{{tp|p=32659211|t=2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.|pdf=|usr=015}}
 +
{{tp|p=C7292579|t=2020. Genotyping SARS-CoV-2 through an interactive web application.|pdf=|usr=015}}
 +
{{tp|p=C7266609|t=2020. An integrated national scale SARS-CoV-2 genomic surveillance network.|pdf=|usr=015}}
 +
{{tp|p=C7351415|t=?. Severe refractory Kawasaki disease in seven infants in the COVID-19 era.|pdf=|usr=015}}
 +
{{tp|p=C7259908|t=2020. Coronavirus is the trigger but the immune response is deadly.|pdf=|usr=015}}
 +
{{tp|p=C7234786|t=2020. Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases.|pdf=|usr=015}}
 +
{{tp|p=32680625|t=2020. Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.|pdf=|usr=015}}
 +
{{tp|p=C7256601|t=?. In Reply?The ?Perfect Cytokine Storm? of COVID-19.|pdf=|usr=015}}
 +
{{tp|p=C7256539|t=2020. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19).|pdf=|usr=015}}
 +
{{tp|p=C7256537|t=?. THE ?PERFECT CYTOKINE STORM? OF COVID-19.|pdf=|usr=015}}
 +
{{tp|p=32721799|t=2020. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression.|pdf=|usr=015}}
 +
{{tp|p=32679425|t=2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.|pdf=|usr=015}}
 +
{{tp|p=32679426|t=2020. The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19?.|pdf=|usr=015}}
 +
{{tp|p=32673940|t=2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.|pdf=|usr=015}}
 +
{{tp|p=32679424|t=2020. Natural protection of ocular surface from viral infections ? A hypothesis.|pdf=|usr=015}}
 +
{{tp|p=32688183|t=2020. Corrigendum to ?COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming?? [Med Hypothesis 144 (2020) 109918].|pdf=|usr=015}}
 +
{{tp|p=C7326438|t=2020. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.|pdf=|usr=015}}
 +
{{tp|p=C7322475|t=2020. COVID-19: NAD+ deficiency may predispose the aged obese and type2 diabetics to mortality through its effect on SIRT1 activity.|pdf=|usr=015}}
 +
{{tp|p=C7313490|t=2020. Understanding Covid and the associated post-infectious hyper-inflammatory state (PIMS-TS) in children.|pdf=|usr=015}}
 +
{{tp|p=C7313483|t=2020. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.|pdf=|usr=015}}
 +
{{tp|p=32670517|t=2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.|pdf=|usr=015}}
 +
{{tp|p=32670592|t=2020. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.|pdf=|usr=015}}
 +
{{tp|p=C7334952|t=2020. Pathologic features of COVID-19: A concise review.|pdf=|usr=015}}
 +
{{tp|p=32703502|t=2020. Autopsy of patients with COVID-19: A balance of fear and curiosity.|pdf=|usr=015}}
 +
{{tp|p=C7346848|t=2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.|pdf=|usr=015}}
 +
{{tp|p=C7328593|t=2020. Behavioral immune system linked to responses to the threat of COVID-19.|pdf=|usr=015}}
 +
{{tp|p=C7329651|t=?. Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case report.|pdf=|usr=015}}
 +
{{tp|p=C7244417|t=?. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach.|pdf=|usr=015}}
 +
{{tp|p=32713710|t=?. Neuropsychiatric Symptoms in an Adolescent Boy With Multisystem Inflammatory Syndrome in Children.|pdf=|usr=015}}
 +
{{tp|p=C7335763|t=?. Histopathologische Befunde bei therapierter und nichttherapierter SARS-CoV-2-Infektion ? Bericht über 3 Autopsien.|pdf=|usr=015}}
 +
{{tp|p=C7335629|t=?. Der erste COVID-19-Hotspot in einer Hamburger Senioreneinrichtung: Präventionskonzept Letalität und Obduktionsbefunde.|pdf=|usr=015}}
 +
{{tp|p=C7247437|t=?. Evidence for systematic autopsies in COVID-19 positive deceased: Case report of the first German investigated COVID-19 death.|pdf=|usr=015}}
 +
{{tp|p=C7311357|t=2020. Expression profiling meta-analysis of ACE2 and TMPRSS2 the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells and identification of putative modulators.|pdf=|usr=015}}
 +
{{tp|p=32702724|t=?. Age-dependent assessment of genes involved in cellular senescence telomere and mitochondrial pathways in human lung tissue of smokers COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis .|pdf=|usr=015}}
 +
{{tp|p=32702726|t=?. SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyper-activation .|pdf=|usr=015}}
 +
{{tp|p=32702716|t=?. Can Hyperperfusion of Nonaerated Lung Explain COVID-19 Hypoxia? .|pdf=|usr=015}}
 +
{{tp|p=32702718|t=?. E-cigarette-Induced Pulmonary Inflammation and Dysregulated Repair are Mediated by nAChR ?7 Receptor: Role of nAChR ?7 in ACE2 Covid-19 receptor regulation.|pdf=|usr=015}}
 +
{{tp|p=32702714|t=?. Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.|pdf=|usr=015}}
 +
{{tp|p=32702737|t=?. B cell clonal expansion and convergent antibody responses to SARS-CoV-2.|pdf=|usr=015}}
 +
{{tp|p=32702728|t=?. A potential role for AHR in SARS-CoV-2 pathology.|pdf=|usr=015}}
 +
{{tp|p=C7347481|t=2020. Hemophagocytic syndrome and COVID-19.|pdf=|usr=015}}
 +
{{tp|p=C7328624|t=2020. Sars-CoV-2 et Kawasaki rapprochement ? risque.|pdf=|usr=015}}
 +
{{tp|p=C7297549|t=?. Kawasaki Disease and Invasive Pneumococcal Infection.|pdf=|usr=015}}
 +
{{tp|p=32680648|t=?. Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak.|pdf=|usr=015}}
 +
head
 +
{{tp|p=C7340772|t=?. Prototype of a Smart Microfluidic Platform for the Evaluation of SARS-Cov-2 Pathogenesis Along with Estimation of the Effectiveness of Potential Drug Candidates and Antigen?Antibody Interactions in Convalescent Plasma Therapy.|pdf=|usr=015}}
 +
{{tp|p=C7358563|t=2020. Unleashing the mysterious link between COVID-19 and a famous childhood vasculitis: Kawasaki disease.|pdf=|usr=015}}
 +
{{tp|p=C7320653|t=?. Fractal signature of coronaviruses related to severe acute respiratory syndrome.|pdf=|usr=015}}
 +
{{tp|p=C7318729|t=2020. Gemeinschaftlich in Krisenzeiten: NMR-Strukturbiologie gegen COVID-19.|pdf=|usr=015}}
 +
{{tp|p=C7297671|t=2020. Covid-19: An urgent need for a psychoneuroendocrine perspective.|pdf=|usr=015}}
 +
{{tp|p=C7344205|t=2020. Crystal Structure of the Main Protease of Human Coronavirus NL63.|pdf=|usr=015}}
 +
{{tp|p=C7225694|t=2020. COVID-19 y estudios microbiológicos post mortem.|pdf=|usr=015}}
 +
{{tp|p=C7211634|t=2020. Autopsias en casos sospechosos de SARS-CoV-2.|pdf=|usr=015}}
 +
{{tp|p=C7211618|t=2020. Gestión de los cadáveres durante la pandemia por COVID-19 en España.|pdf=|usr=015}}
 +
{{tp|p=C7334659|t=2020. Devilishly radical NETwork in COVID-19: Oxidative stress neutrophil extracellular traps (NETs) and T cell suppression.|pdf=|usr=015}}
 +
{{tp|p=C7292949|t=2020. NK cells: A double edge sword against SARS-CoV-2.|pdf=|usr=015}}
 +
{{tp|p=C7315969|t=?. COVID-19 and preeclampsia with severe features at 34-weeks gestation.|pdf=|usr=015}}
 +
{{tp|p=32668317|t=?. COVID-19?Related Collapsing Glomerulopathy in a Kidney Transplant Recipient.|pdf=|usr=015}}
 +
{{tp|p=32659225|t=?. The role of a cytokine storm in severe COVID-19 disease in pregnancy.|pdf=|usr=015}}
 +
{{tp|p=32659620|t=2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.|pdf=|usr=015}}
 +
{{tp|p=C7314264|t=?. Human neutralizing antibodies to SARS-CoV-2: views and perspectives from Professor Linqi Zhang at Tsinghua University.|pdf=|usr=015}}
 +
{{tp|p=32718664|t=?. Afectación endotelial por COVID-19 en criobiopsia pulmonar.|pdf=|usr=015}}
 +
{{tp|p=32682575|t=?. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.|pdf=|usr=015}}
 +
{{tp|p=C7323440|t=?. Children s (and autoimmune patients) morbidity (and mortality) from Covid?19 is similar to the general population: immunologic rationale.|pdf=|usr=015}}
 +
{{tp|p=C7305885|t=2020. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.|pdf=|usr=015}}
 +
{{tp|p=32703419|t=2020. Proteasome activator PA28?-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.|pdf=|usr=015}}
 +
{{tp|p=C7356136|t=2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.|pdf=|usr=015}}
 +
{{tp|p=32601146|t=2020. Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.|pdf=|usr=015}}
 +
{{tp|p=32665075|t=?. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.|pdf=|usr=015}}
 +
{{tp|p=C7308744|t=2020. Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk.|pdf=|usr=015}}
 +
{{tp|p=32673567|t=?. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.|pdf=|usr=015}}
 +
{{tp|p=32697970|t=?. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.|pdf=|usr=015}}
 +
{{tp|p=32697968|t=?. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.|pdf=|usr=015}}
 +
{{tp|p=C7091918|t=?. COVID-19 infection: the perspectives on immune responses.|pdf=|usr=015}}
 +
{{tp|p=32735849|t=?. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.|pdf=|usr=015}}
 +
{{tp|p=32668215|t=2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.|pdf=|usr=015}}
 +
{{tp|p=C7276302|t=2020. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.|pdf=|usr=015}}
 +
{{tp|p=32673562|t=2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.|pdf=|usr=015}}
 +
{{tp|p=32673668|t=2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.|pdf=|usr=015}}
 +
{{tp|p=32673711|t=2020. mTORC inhibitor Sirolimus deprograms monocytes in ?cytokine storm? in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome.|pdf=|usr=015}}
 +
{{tp|p=32659373|t=2020. Long-term infection of SARS-CoV-2 changed the body s immune status.|pdf=|usr=015}}
 +
{{tp|p=C7245680|t=?. Hyperinflammation with COVID-19: The key to patient deterioration????.|pdf=|usr=015}}
 +
{{tp|p=C7354860|t=2020. Citrullinated histone H3 a marker of extracellular trap formation is increased in blood of stable asthma patients.|pdf=|usr=015}}
 +
{{tp|p=32696004|t=2020. Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors.|pdf=|usr=015}}
 +
{{tp|p=32711241|t=2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.|pdf=|usr=015}}
 +
{{tp|p=C7287426|t=?. On the evolutionary epidemiology of SARS-CoV-2.|pdf=|usr=015}}
 +
{{tp|p=C7328575|t=?. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.|pdf=|usr=015}}
 +
{{tp|p=C7354376|t=?. Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays.|pdf=|usr=015}}
 +
{{tp|p=32711184|t=2020. The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2.|pdf=|usr=015}}
 +
{{tp|p=C7335417|t=?. Assessment of samples pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia.|pdf=|usr=015}}
 +
{{tp|p=32673978|t=2020. How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory.|pdf=|usr=015}}
 +
{{tp|p=32731192|t=2020. COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic.|pdf=|usr=015}}
 +
{{tp|p=C7316051|t=2020. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.|pdf=|usr=015}}
 +
{{tp|p=C7305505|t=2020. Tocilizumab for treatment of patients with severe COVID?19: A retrospective cohort study.|pdf=|usr=015}}
 +
{{tp|p=C7245291|t=?. EL CUIDADO HUMANIZADO EN LA MUERTE POR COVID-19: A PROPÓSITO DE UN CASO.|pdf=|usr=015}}
 +
{{tp|p=C7357538|t=?. Particulate matter (PM10) enhances RNA virus infection through modulation of innate immune responses?.|pdf=|usr=015}}
 +
{{tp|p=C7358302|t=?. A Study on Herd Immunity of COVID-19 in South Korea: Using a Stochastic Economic-Epidemiological Model.|pdf=|usr=015}}
 +
{{tp|p=32665942|t=2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.|pdf=|usr=015}}
 +
{{tp|p=C7267447|t=2020. An address to the European immunology community concerning the Coronavirus pandemic.|pdf=|usr=015}}
 +
{{tp|p=C7318732|t=2020. Can India develop herd immunity against COVID-19?|pdf=|usr=015}}
 +
{{tp|p=C7262083|t=?. SARS?CoV?2 an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability.|pdf=|usr=015}}
 +
{{tp|p=C7337683|t=?. Lions Tigers and Kittens too: ACE2 and susceptibility to CoVID-19.|pdf=|usr=015}}
 +
{{tp|p=C7337764|t=?. COVID-19 and Evolutionary Medicine.|pdf=|usr=015}}
 +
{{tp|p=C7324322|t=2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?|pdf=|usr=015}}
  
===Neutralizing antibodies===
+
{{tp|p=32656452|t=2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.|pdf=|usr=015}}
{{tp|p=32454513|t=2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection.|pdf=|usr=007}}
+
{{tp|p=32631771|t=2020. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.|pdf=|usr=015}}
{{tp|p=32454512|t=2020. A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.|pdf=|usr=007}}
+
{{tp|p=32598981|t=2020. Infections and Collapsing Glomerulopathy.|pdf=|usr=015}}
{{tp|p=32497196|t=2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.|pdf=|usr=007}}
+
{{tp|p=32564928|t=2020. Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges.|pdf=|usr=015}}
{{ttp|p=32073157|t=2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |pdf=|usr=}}
+
{{tp|p=32653819|t=2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.|pdf=|usr=015}}
{{tp|p=32515685|t=2020. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.|pdf=|usr=008}}
+
{{tp|p=32571869|t=2020. Kawasaki disease or Kawasaki syndrome?|pdf=|usr=015}}
{{tp|p=32514035|t=2020. Dissecting antibody-mediated protection against SARS-CoV-2.|pdf=|usr=009}}
+
{{tp|p=32489438|t=2020. Spectrum of histopathological findings in coronavirus disease-19, Middle East respiratory syndrome and severe acute respiratory syndrome.|pdf=|usr=015}}
{{tp|p=32561270|t=2020. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.|pdf=|usr=011}}
+
{{tp|p=32565134|t=2020. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.|pdf=|usr=015}}
 +
{{tp|p=32533513|t=2020. Cytosolic DNA sensing through cGAS and STING is inactivated by gene mutations in pangolins.|pdf=|usr=015}}
 +
{{tp|p=32405132|t=2020. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury.|pdf=|usr=015}}
 +
{{tp|p=32653765|t=2020. Immunosenescence exacerbates the COVID-19.|pdf=|usr=015}}
 +
{{tp|p=32611485|t=2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.|pdf=|usr=015}}
 +
{{tp|p=32651741|t=2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.|pdf=|usr=015}}
 +
{{tp|p=32559654|t=2020. Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling.|pdf=|usr=015}}
 +
{{tp|p=32646445|t=2020. Isolation and characterization of WUPyV in polarized human airway epithelial cells.|pdf=|usr=015}}
 +
{{tp|p=32618551|t=2020. Covid-19 and Kawasaki syndrome.|pdf=|usr=015}}
 +
{{tp|p=32645325|t=2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.|pdf=|usr=015}}
 +
{{tp|p=32645326|t=2020. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.|pdf=|usr=015}}
 +
{{tp|p=32649876|t=2020. Human Virus Transcriptional Regulators.|pdf=|usr=015}}
 +
{{tp|p=32623480|t=2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.|pdf=|usr=015}}
 +
{{tp|p=32623546|t=2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.|pdf=|usr=015}}
 +
{{tp|p=32632255|t=2020. Pulmonary alveolar regeneration in adult COVID-19 patients.|pdf=|usr=015}}
 +
{{tp|p=32612199|t=2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.|pdf=|usr=015}}
 +
{{tp|p=32622823|t=2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.|pdf=|usr=015}}
 +
{{tp|p=32622819|t=2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.|pdf=|usr=015}}
 +
{{tp|p=32118646|t=2020. Voice from China: nomenclature of the novel coronavirus and related diseases.|pdf=|usr=015}}
 +
{{tp|p=32118645|t=2020. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-novel coronavirus.|pdf=|usr=015}}
 +
{{tp|p=32653658|t=2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.|pdf=|usr=015}}
 +
{{tp|p=32533338|t=2020. A 9-year-old girl with Kawasaki disease and pulmonary nodules.|pdf=|usr=015}}
 +
{{tp|p=32418043|t=2020. Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis.|pdf=|usr=015}}
 +
{{tp|p=32513224|t=2020. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.|pdf=|usr=015}}
 +
{{tp|p=32541570|t=2020. Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 ARDS Patients With Near-Normal Respiratory Compliance.|pdf=|usr=015}}
 +
{{tp|p=32642354|t=2020. Do COVID-19 and SARS Gene Complexities and Variations Help Overcome the Knowledge Gap?|pdf=|usr=015}}
 +
{{tp|p=32428465|t=2020. Pandemics and the great evolutionary mismatch.|pdf=|usr=015}}
 +
{{tp|p=32563779|t=2020. Protective and pathogenic roles for mast cells during viral infections.|pdf=|usr=015}}
 +
{{tp|p=32484440|t=2020. Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells.|pdf=|usr=015}}
 +
{{tp|p=32617121|t=2020. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019.|pdf=|usr=015}}
 +
{{tp|p=24935083|t=2015. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.|pdf=|usr=015}}
 +
{{tp|p=23452147|t=2013. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.|pdf=|usr=015}}
 +
{{tp|p=32641214|t=2020. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.|pdf=|usr=015}}
 +
{{tp|p=32637365|t=2020. Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier.|pdf=|usr=015}}
 +
{{tp|p=32655580|t=2020. Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?|pdf=|usr=015}}
 +
{{tp|p=32655579|t=2020. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.|pdf=|usr=015}}
 +
{{tp|p=32612617|t=2020. The COVID-19 Cytokine Storm; What We Know So Far.|pdf=|usr=015}}
 +
{{tp|p=32582219|t=2020. IL-22 Plays a Critical Role in Maintaining Epithelial Integrity During Pulmonary Infection.|pdf=|usr=015}}
 +
{{tp|p=32574256|t=2020. Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection.|pdf=|usr=015}}
 +
{{tp|p=32626680|t=2020. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study.|pdf=|usr=015}}
 +
{{tp|p=32392463|t=2020. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.|pdf=|usr=015}}
 +
{{tp|p=32294404|t=2020. Something Else to Stress about: Perinatal Stress Attenuates CD8(+) T Cell Activity in Adults.|pdf=|usr=015}}
 +
{{tp|p=32500198|t=2020. Corona deaths in Hamburg, Germany.|pdf=|usr=015}}
 +
{{tp|p=32626922|t=2020. A dissection of SARSCoV2 with clinical implications (Review).|pdf=|usr=015}}
 +
{{tp|p=32466119|t=2020. Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.|pdf=|usr=015}}
 +
{{tp|p=32365944|t=2020. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.|pdf=|usr=015}}
 +
{{tp|p=32340172|t=2020. Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway.|pdf=|usr=015}}
 +
{{tp|p=32488343|t=2020. Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients.|pdf=|usr=015}}
 +
{{tp|p=32385629|t=2020. From the quarantine diary of an emergency physician: the coronavirus and the dysautonomic storm.|pdf=|usr=015}}
 +
{{tp|p=17340620|t=2007. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung.|pdf=|usr=015}}
 +
{{tp|p=28063205|t=2017. Pathogenetic determinants in Kawasaki disease: the haematological point of view.|pdf=|usr=015}}
 +
{{tp|p=30146782|t=2019. Modulation of the immune response by Middle East respiratory syndrome coronavirus.|pdf=|usr=015}}
 +
{{tp|p=32648027|t=2020. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.|pdf=|usr=015}}
 +
{{tp|p=32623351|t=2020. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates.|pdf=|usr=015}}
 +
{{tp|p=16752365|t=2006. Coronavirus phylogeny based on 2D graphical representation of DNA sequence.|pdf=|usr=015}}
 +
{{tp|p=32006540|t=2020. Genetic diversity and potential recombination between ferret coronaviruses from European and American lineages.|pdf=|usr=015}}
 +
{{tp|p=32142930|t=2020. Insights into the cross-species evolution of 2019 novel coronavirus.|pdf=|usr=015}}
 +
{{tp|p=26287378|t=2016. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.|pdf=|usr=015}}
 +
{{tp|p=24760654|t=2014. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.|pdf=|usr=015}}
 +
{{tp|p=32585239|t=2020. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.|pdf=|usr=015}}
 +
{{tp|p=32441751|t=2020. Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome.|pdf=|usr=015}}
 +
{{tp|p=32582339|t=2020. Variation of 2019 novel coronavirus complete genomes recorded in the 1(st) month of outbreak: Implication for mutation.|pdf=|usr=015}}
 +
{{tp|p=32188728|t=2020. Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.|pdf=|usr=015}}
 +
{{tp|p=26269185|t=2015. Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.|pdf=|usr=015}}
 +
{{tp|p=24478444|t=2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.|pdf=|usr=015}}
 +
{{tp|p=16940539|t=2006. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein.|pdf=|usr=015}}
 +
{{tp|p=32432657|t=2020. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.|pdf=|usr=015}}
 +
{{tp|p=32437764|t=2020. Visualization of putative coronavirus in kidney.|pdf=|usr=015}}
 +
{{tp|p=32505464|t=2020. Am I a coronavirus?|pdf=|usr=015}}
 +
{{tp|p=32653518|t=2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.|pdf=|usr=015}}
 +
{{tp|p=32498008|t=2020. Is the gingival sulcus a potential niche for SARS-Corona virus-2?|pdf=|usr=015}}
 +
{{tp|p=32652428|t=2020. Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?|pdf=|usr=015}}
 +
{{tp|p=32634734|t=2020. Hypoxemia in COVID-19 patients: An hypothesis.|pdf=|usr=015}}
 +
{{tp|p=32653475|t=2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?|pdf=|usr=015}}
 +
{{tp|p=32656314|t=2020. COVID-19-A theory of autoimmunity to ACE-2.|pdf=|usr=015}}
 +
{{tp|p=25077179|t=2014. Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.|pdf=|usr=015}}
 +
{{tp|p=32598829|t=2020. Childhood Multisystem Inflammatory Syndrome - A New Challenge in the Pandemic.|pdf=|usr=015}}
 +
{{tp|p=32461612|t=2020. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.|pdf=|usr=015}}
 +
{{tp|p=32555182|t=2020. Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution.|pdf=|usr=015}}
 +
{{tp|p=32651568|t=2020. T cell renaissance in COVID-19.|pdf=|usr=015}}
 +
{{tp|p=32591759|t=2020. Caught by NETs.|pdf=|usr=015}}
 +
{{tp|p=32591758|t=2020. Transient IgA, steady IgG?|pdf=|usr=015}}
 +
{{tp|p=32533112|t=2020. Neutralizing antibodies in convalescent patients.|pdf=|usr=015}}
 +
{{tp|p=32533130|t=2020. Epigenetic and epitranscriptomic regulation of viral replication.|pdf=|usr=015}}
 +
{{tp|p=32561857|t=2020. Coronavirus replication factories.|pdf=|usr=015}}
 +
{{tp|p=32287794|t=2020. Wuhan-like virus discovered seven years ago.|pdf=|usr=015}}
 +
{{tp|p=31863580|t=2020. A nucleobase-binding pocket in a viral RNA-dependent RNA polymerase contributes to elongation complex stability.|pdf=|usr=015}}
 +
{{tp|p=30070073|t=2018. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease.|pdf=|usr=015}}
 +
{{tp|p=28950425|t=2018. Pulmonary presentation of Kawasaki disease-A diagnostic challenge.|pdf=|usr=015}}
 +
{{tp|p=22022266|t=2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.|pdf=|usr=015}}
 +
{{tp|p=32620366|t=2020. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.|pdf=|usr=015}}
 +
{{tp|p=32611518|t=2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.|pdf=|usr=015}}
 +
{{tp|p=32650970|t=2020. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.|pdf=|usr=015}}
 +
{{tp|p=32650969|t=2020. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic.|pdf=|usr=015}}
 +
{{tp|p=32434680|t=2020. AID in Antibody Diversification: There and Back Again.|pdf=|usr=015}}
 +
{{tp|p=32651761|t=2020. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.|pdf=|usr=015}}
 +
{{tp|p=28738245|t=2017. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication.|pdf=|usr=015}}
 +
{{tp|p=18045721|t=2008. SARS coronavirus accessory proteins.|pdf=|usr=015}}
 +
{{tp|p=32456011|t=2020. The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses.|pdf=|usr=015}}
 +
{{tp|p=32331321|t=2020. Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?|pdf=|usr=015}}
  
 +
{{tp|p=32656452|t=2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.|pdf=|usr=014}}
 +
{{tp|p=32712145|t=2020. Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult.|pdf=|usr=014}}
 +
{{tp|p=32659225|t=2020. The role of a cytokine storm in severe COVID-19 disease in pregnancy.|pdf=|usr=014}}
 +
{{tp|p=32701539|t=2020. HLA-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.|pdf=|usr=014}}
 +
{{tp|p=32659620|t=2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.|pdf=|usr=014}}
 +
{{tp|p=32653819|t=2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.|pdf=|usr=014}}
 +
{{tp|p=32676824|t=2020. Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.|pdf=|usr=014}}
 +
{{tp|p=32708525|t=2020. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.|pdf=|usr=014}}
 +
{{tp|p=32669265|t=2020. Discovery of M Protease inhibitors encoded by SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32708430|t=2020. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.|pdf=|usr=014}}
 +
{{tp|p=32653765|t=2020. Immunosenescence exacerbates the COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32651741|t=2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32717432|t=2020. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.|pdf=|usr=014}}
 +
{{tp|p=32685484|t=2020. Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.|pdf=|usr=014}}
 +
{{tp|p=32664932|t=2020. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?|pdf=|usr=014}}
 +
{{tp|p=32664879|t=2020. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.|pdf=|usr=014}}
 +
{{tp|p=32665075|t=2020. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32708264|t=2020. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32645325|t=2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.|pdf=|usr=014}}
 +
{{tp|p=32697970|t=2020. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.|pdf=|usr=014}}
 +
{{tp|p=32697968|t=2020. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.|pdf=|usr=014}}
 +
{{tp|p=32673567|t=2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.|pdf=|usr=014}}
 +
{{tp|p=32690996|t=2020. COVID-19 infection: mitohormetic concept of immune response.|pdf=|usr=014}}
 +
{{tp|p=32697943|t=2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.|pdf=|usr=014}}
 +
{{tp|p=32612152|t=2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32623480|t=2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.|pdf=|usr=014}}
 +
{{tp|p=32712910|t=2020. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.|pdf=|usr=014}}
 +
{{tp|p=32623546|t=2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.|pdf=|usr=014}}
 +
{{tp|p=32668215|t=2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.|pdf=|usr=014}}
 +
{{tp|p=32632255|t=2020. Pulmonary alveolar regeneration in adult COVID-19 patients.|pdf=|usr=014}}
 +
{{tp|p=32612199|t=2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.|pdf=|usr=014}}
 +
{{tp|p=32673562|t=2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.|pdf=|usr=014}}
 +
{{tp|p=32619549|t=2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.|pdf=|usr=014}}
 +
{{tp|p=32660065|t=2020. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.|pdf=|usr=014}}
 +
{{tp|p=32635598|t=2020. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32707842|t=2020. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.|pdf=|usr=014}}
 +
{{tp|p=32622823|t=2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.|pdf=|usr=014}}
 +
{{tp|p=32707182|t=2020. Novel Temperature Trajectory Subphenotypes in COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32622819|t=2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.|pdf=|usr=014}}
 +
{{tp|p=32630212|t=2020. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.|pdf=|usr=014}}
 +
{{tp|p=32700055|t=2020. The extended autonomic system, dyshomeostasis, and COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32671502|t=2020. Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis.|pdf=|usr=014}}
 +
{{tp|p=32661775|t=2020. Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna's Autonomic Unit.|pdf=|usr=014}}
 +
{{tp|p=32673668|t=2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32683814|t=2020. Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic?|pdf=|usr=014}}
 +
{{tp|p=32664709|t=2020. Immunopathogenesis of COVID-19 and early immunomodulators.|pdf=|usr=014}}
 +
{{tp|p=32712394|t=2020. Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation?|pdf=|usr=014}}
 +
{{tp|p=32659373|t=2020. Long-term infection of SARS-CoV-2 changed the body's immune status.|pdf=|usr=014}}
 +
{{tp|p=32653662|t=2020. Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32653658|t=2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.|pdf=|usr=014}}
 +
{{tp|p=32717416|t=2020. Evolution of viral quasispecies during SARS-CoV-2 infection.|pdf=|usr=014}}
 +
{{tp|p=32711057|t=2020. Viable SARS-CoV-2 in various specimens from COVID-19 patients.|pdf=|usr=014}}
 +
{{tp|p=32688067|t=2020. Body temperature and host species preferences of SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32658736|t=2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.|pdf=|usr=014}}
 +
{{tp|p=32709253|t=2020. Response to "Body temperature correlates with mortality in COVID-19 patients".|pdf=|usr=014}}
 +
{{tp|p=32698857|t=2020. Could the severity of COVID-19 be increased by low gastric acidity?|pdf=|usr=014}}
 +
{{tp|p=32690058|t=2020. Detection of IgG antibody during the follow-up in patients with COVID-19 infection.|pdf=|usr=014}}
 +
{{tp|p=32711241|t=2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.|pdf=|usr=014}}
 +
{{tp|p=32685628|t=2020. Haematological and immunological data of Chinese children infected with coronavirus disease 2019.|pdf=|usr=014}}
 +
{{tp|p=32707212|t=2020. Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus.|pdf=|usr=014}}
 +
{{tp|p=32665025|t=2020. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32699547|t=2020. Kawasaki disease in siblings and a review of drug treatment.|pdf=|usr=014}}
 +
{{tp|p=32711256|t=2020. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=014}}
 +
{{tp|p=32711254|t=2020. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.|pdf=|usr=014}}
 +
{{tp|p=32707445|t=2020. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.|pdf=|usr=014}}
 +
{{tp|p=32717182|t=2020. Lessons for COVID-19 Immunity from Other Coronavirus Infections.|pdf=|usr=014}}
 +
{{tp|p=32712315|t=2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.|pdf=|usr=014}}
 +
{{tp|p=32707288|t=2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32668462|t=2020. COVID-19: An Immunopathologic Assault.|pdf=|usr=014}}
 +
{{tp|p=32709193|t=2020. Lung Injury in COVID-19-An Emerging Hypothesis.|pdf=|usr=014}}
 +
{{tp|p=32673476|t=2020. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.|pdf=|usr=014}}
 +
{{tp|p=32672403|t=2020. microRNAs as new possible actors in gender disparities of Covid-19 pandemic.|pdf=|usr=014}}
 +
{{tp|p=32662161|t=2020. Covid-19, ACE2, and the kidney.|pdf=|usr=014}}
 +
{{tp|p=32681166|t=2020. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.|pdf=|usr=014}}
 +
{{tp|p=32666092|t=2020. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.|pdf=|usr=014}}
 +
{{tp|p=32662111|t=2020. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes.|pdf=|usr=014}}
 +
{{tp|p=32706609|t=2020. Inducible Epithelial Resistance Against Coronavirus Pneumonia in Mice.|pdf=|usr=014}}
 +
{{tp|p=32663409|t=2020. Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32662396|t=2020. Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients.|pdf=|usr=014}}
 +
{{tp|p=32705809|t=2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1.|pdf=|usr=014}}
 +
{{tp|p=32716641|t=2020. Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model.|pdf=|usr=014}}
 +
{{tp|p=32686774|t=2020. Multiple sclerosis and COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32654296|t=2020. A Tale of (Glycogen Synthase Kinase) Three: Lithium, The Kidney and Coronavirus Disease 19.|pdf=|usr=014}}
 +
{{tp|p=32679621|t=2020. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.|pdf=|usr=014}}
 +
{{tp|p=32678953|t=2020. Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series.|pdf=|usr=014}}
 +
{{tp|p=32678950|t=2020. Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.|pdf=|usr=014}}
 +
{{tp|p=32663362|t=2020. ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.|pdf=|usr=014}}
 +
{{tp|p=32654514|t=2020. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression.|pdf=|usr=014}}
 +
{{tp|p=32689809|t=2020. Unexpected Features of Cardiac Pathology in COVID-19 Infection.|pdf=|usr=014}}
 +
{{tp|p=32706417|t=2020. Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32717055|t=2020. Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.|pdf=|usr=014}}
 +
{{tp|p=32710613|t=2020. Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.|pdf=|usr=014}}
 +
{{tp|p=32672790|t=2020. Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.|pdf=|usr=014}}
 +
{{tp|p=32667973|t=2020. SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.|pdf=|usr=014}}
 +
{{tp|p=32663256|t=2020. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.|pdf=|usr=014}}
 +
{{tp|p=32694169|t=2020. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?|pdf=|usr=014}}
 +
{{tp|p=32713339|t=2020. Viral Evolution will Automatically Resolve COVID-19 Pandemic.|pdf=|usr=014}}
 +
{{tp|p=32660402|t=2020. NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32657802|t=2020. Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: menage a trois.|pdf=|usr=014}}
 +
{{tp|p=32675718|t=2020. Reflections on rheumatological aspects of COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32654350|t=2020. Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection.|pdf=|usr=014}}
 +
{{tp|p=32662099|t=2020. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.|pdf=|usr=014}}
 +
{{tp|p=32657473|t=2020. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.|pdf=|usr=014}}
 +
{{tp|p=32652001|t=2020. Endocrine significance of SARS-CoV-2's reliance on ACE2.|pdf=|usr=014}}
 +
{{tp|p=32686577|t=2020. Epigenetic mechanisms regulating COVID-19 infection.|pdf=|usr=014}}
 +
{{tp|p=32710612|t=2020. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32643968|t=2020. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.|pdf=|usr=014}}
 +
{{tp|p=32706090|t=2020. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.|pdf=|usr=014}}
 +
{{tp|p=32692465|t=2020. COVID-19, Cilia, and Smell.|pdf=|usr=014}}
 +
{{tp|p=32692408|t=2020. Third Trimester Placentas of SARS-CoV-2-Positive Women: Histomorphology, including Viral Immunohistochemistry and in Situ Hybridization.|pdf=|usr=014}}
 +
{{tp|p=32678695|t=2020. Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.|pdf=|usr=014}}
 +
{{tp|p=32689852|t=2020. Immune Responses to the Novel Coronavirus-2: Friend or Foe?|pdf=|usr=014}}
  
===Innate immunology===
+
{{tp|p=32662421|t=2020. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?|pdf=|usr=014}}
{{ttp|p=32291557|t=ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells |pdf=|usr=}}
+
{{tp|p=32665942|t=2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.|pdf=|usr=014}}
{{tp|p=32198201|t=2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors |pdf=|usr=}}
+
{{tp|p=32675207|t=2020. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.|pdf=|usr=014}}
{{tp|p=32374430|t=2020. DC/L-SIGNs of Hope in the COVID-19 Pandemic |pdf=|usr=}}
+
{{tp|p=32675206|t=2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.|pdf=|usr=014}}
{{tp|p=32361001|t=ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes |pdf=|usr=}}
+
{{tp|p=32703822|t=2020. Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge.|pdf=|usr=014}}
{{tp|p=32248387|t=ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution |pdf=|usr=}}
+
{{tp|p=32714336|t=2020. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.|pdf=|usr=014}}
{{ttp|p=32407669|t=ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients |pdf=|usr=}}
+
{{tp|p=32676080|t=2020. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.|pdf=|usr=014}}
{{tp|p=32456409|t=2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.|pdf=|usr=007}}
+
{{tp|p=32670298|t=2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.|pdf=|usr=014}}
{{ttp|p=32156572|t=2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation |pdf=|usr=}}
+
{{tp|p=32695025|t=2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.|pdf=|usr=014}}
{{ttp|p=32454408|t=2020. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.|pdf=|usr=008}}
+
{{tp|p=32676039|t=2020. COVID-19 Sepsis and Microcirculation Dysfunction.|pdf=|usr=014}}
{{tp|p=32524333|t=2020. COVID 19: a clue from innate immunity.|pdf=|usr=008}}
+
{{tp|p=32658591|t=2020. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.|pdf=|usr=014}}
{{tp|p=32464098|t=2020. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?|pdf=|usr=008}}
+
{{tp|p=32682765|t=2020. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19.|pdf=|usr=014}}
{{ttp|p=32599245|t=2020. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.|pdf=|usr=011}}
+
{{tp|p=32668194|t=2020. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.|pdf=|usr=014}}
{{ttp|p=32574272|t=2020. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?|pdf=|usr=011}}
+
{{tp|p=32659267|t=2020. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.|pdf=|usr=014}}
 +
{{tp|p=32683337|t=2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32683336|t=2020. Hyperinflammatory Syndrome in Children Associated with COVID-19: Need for Awareness.|pdf=|usr=014}}
 +
{{tp|p=32659347|t=2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.|pdf=|usr=014}}
 +
{{tp|p=32708334|t=2020. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.|pdf=|usr=014}}
 +
{{tp|p=32668803|t=2020. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.|pdf=|usr=014}}
 +
{{tp|p=32664543|t=2020. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.|pdf=|usr=014}}
 +
{{tp|p=32681297|t=2020. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?|pdf=|usr=014}}
 +
{{tp|p=32666177|t=2020. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.|pdf=|usr=014}}
 +
{{tp|p=32695405|t=2020. COVID-19 and cryo-EM.|pdf=|usr=014}}
 +
{{tp|p=32675285|t=2020. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.|pdf=|usr=014}}
 +
{{tp|p=32701511|t=2020. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children.|pdf=|usr=014}}
 +
{{tp|p=32708872|t=2020. Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.|pdf=|usr=014}}
 +
{{tp|p=32674356|t=2020. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.|pdf=|usr=014}}
 +
{{tp|p=32690544|t=2020. Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2.|pdf=|usr=014}}
 +
{{tp|p=32707511|t=2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.|pdf=|usr=014}}
 +
{{tp|p=32674001|t=2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.|pdf=|usr=014}}
 +
{{tp|p=32652214|t=2020. Factors affecting stability and infectivity of SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32699345|t=2020. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32675312|t=2020. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32652168|t=2020. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).|pdf=|usr=014}}
 +
{{tp|p=32718895|t=2020. Immune response in COVID-19: A review.|pdf=|usr=014}}
 +
{{tp|p=32707537|t=2020. Hazards of the cytokine storm and cytokine-targeted therapy in COVID-19 patients: A Review.|pdf=|usr=014}}
 +
{{tp|p=32627759|t=2020. An Overview of the Genetic Variations of the SARS-CoV-2 Genomes Isolated in Southeast Asian Countries.|pdf=|usr=014}}
 +
{{tp|p=32710986|t=2020. Mutations Strengthened SARS-CoV-2 Infectivity.|pdf=|usr=014}}
 +
{{tp|p=32717229|t=2020. Epidemiological trends in Kawasaki disease during COVID-19 in Singapore.|pdf=|usr=014}}
 +
{{tp|p=32661139|t=2020. Broad and differential animal ACE2 receptor usage by SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32706339|t=2020. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.|pdf=|usr=014}}
 +
{{tp|p=32687484|t=2020. Severe immunosuppression and not a cytokine storm characterize COVID-19 infections.|pdf=|usr=014}}
 +
{{tp|p=32659211|t=2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32682491|t=2020. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.|pdf=|usr=014}}
 +
{{tp|p=32653054|t=2020. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.|pdf=|usr=014}}
 +
{{tp|p=32653518|t=2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.|pdf=|usr=014}}
 +
{{tp|p=32693241|t=2020. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.|pdf=|usr=014}}
 +
{{tp|p=32687918|t=2020. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.|pdf=|usr=014}}
 +
{{tp|p=32703818|t=2020. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.|pdf=|usr=014}}
 +
{{tp|p=32694143|t=2020. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32679426|t=2020. The <> able to explain the Th1 immune lockdown in severe COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32679424|t=2020. Natural protection of ocular surface from viral infections - A hypothesis.|pdf=|usr=014}}
 +
{{tp|p=32673940|t=2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.|pdf=|usr=014}}
 +
{{tp|p=32683222|t=2020. The immunomodulatory effects of exercise against COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32679425|t=2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.|pdf=|usr=014}}
 +
{{tp|p=32664116|t=2020. Late histological findings in symptomatic COVID-19 patients: A case report.|pdf=|usr=014}}
 +
{{tp|p=32670525|t=2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.|pdf=|usr=014}}
 +
{{tp|p=32670517|t=2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.|pdf=|usr=014}}
 +
{{tp|p=32653475|t=2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?|pdf=|usr=014}}
 +
{{tp|p=32710269|t=2020. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32709887|t=2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.|pdf=|usr=014}}
 +
{{tp|p=32709886|t=2020. Structural basis of RNA cap modification by SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32708840|t=2020. Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection.|pdf=|usr=014}}
 +
{{tp|p=32672799|t=2020. Eosinopenia and COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32680910|t=2020. Kidney Biopsy Findings in Patients with COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32675304|t=2020. Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32669323|t=2020. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32660970|t=2020. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.|pdf=|usr=014}}
 +
{{tp|p=32651224|t=2020. Caution in Identifying Coronaviruses by Electron Microscopy.|pdf=|usr=014}}
 +
{{tp|p=32700513|t=2020. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?|pdf=|usr=014}}
 +
{{tp|p=32660959|t=2020. Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva?|pdf=|usr=014}}
 +
{{tp|p=32667280|t=2020. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.|pdf=|usr=014}}
 +
{{tp|p=32699160|t=2020. COVID-19: Complement, Coagulation, and Collateral Damage.|pdf=|usr=014}}
 +
{{tp|p=32696489|t=2020. Cytokine storm syndrome in coronavirus disease 2019: A narrative review.|pdf=|usr=014}}
 +
{{tp|p=32716059|t=2020. Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".|pdf=|usr=014}}
 +
{{tp|p=32710647|t=2020. Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.|pdf=|usr=014}}
 +
{{tp|p=32706425|t=2020. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32706420|t=2020. Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.|pdf=|usr=014}}
 +
{{tp|p=32706410|t=2020. SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.|pdf=|usr=014}}
 +
{{tp|p=32706407|t=2020. SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.|pdf=|usr=014}}
 +
{{tp|p=32681651|t=2020. COVID-19: What type of cytokine storm are we dealing with?|pdf=|usr=014}}
 +
{{tp|p=32699095|t=2020. Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.|pdf=|usr=014}}
 +
{{tp|p=32679087|t=2020. COVID-19: from rapid genome sequencing to fast decisions.|pdf=|usr=014}}
 +
{{tp|p=32654359|t=2020. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.|pdf=|usr=014}}
 +
{{tp|p=32687176|t=2020. Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design.|pdf=|usr=014}}
 +
{{tp|p=32706959|t=2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.|pdf=|usr=014}}
 +
{{tp|p=32706954|t=2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.|pdf=|usr=014}}
 +
{{tp|p=32678534|t=2020. Pulmonary Vascular Pathology in Covid-19. Reply.|pdf=|usr=014}}
 +
{{tp|p=32678533|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=014}}
 +
{{tp|p=32678532|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=014}}
 +
{{tp|p=32678531|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=014}}
 +
{{tp|p=32719485|t=2020. Sampling the host response to SARS-CoV-2 in hospitals under siege.|pdf=|usr=014}}
 +
{{tp|p=32661393|t=2020. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32704094|t=2020. LY6E impairs coronavirus fusion and confers immune control of viral disease.|pdf=|usr=014}}
 +
{{tp|p=32669681|t=2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.|pdf=|usr=014}}
 +
{{tp|p=32717743|t=2020. Longitudinal analyses reveal immunological misfiring in severe COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32668444|t=2020. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.|pdf=|usr=014}}
 +
{{tp|p=32659783|t=2020. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32661414|t=2020. A race to determine what drives COVID-19 severity.|pdf=|usr=014}}
 +
{{tp|p=32684080|t=2020. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.|pdf=|usr=014}}
 +
{{tp|p=32659199|t=2020. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?|pdf=|usr=014}}
 +
{{tp|p=32654247|t=2020. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.|pdf=|usr=014}}
 +
{{tp|p=32672025|t=2020. Immunite cellulaire contre SARS-CoV-2 : substrat de l'immunite croisee entre coronavirus saisonniers et SARS-CoV-2 ?|pdf=|usr=014}}
 +
{{tp|p=32686248|t=2020. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.|pdf=|usr=014}}
 +
{{tp|p=32671966|t=2020. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.|pdf=|usr=014}}
 +
{{tp|p=32656939|t=2020. Lessons from dermatology about inflammatory responses in Covid-19.|pdf=|usr=014}}
 +
{{tp|p=32668509|t=2020. Variabilidad genetica y epigenetica, y la pandemia de Covid-19.|pdf=|usr=014}}
 +
{{tp|p=32697854|t=2020. Interferon: the invisible link between COVID-19 and BCGitis female protection?|pdf=|usr=014}}
 +
{{tp|p=32697367|t=2020. inverted question markAre Superantigens the Cause of Cytokine Storm and viral sepsis in Severe COVID-19? Observations and hypothesis.|pdf=|usr=014}}
 +
{{tp|p=32680954|t=2020. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.|pdf=|usr=014}}
 +
{{tp|p=32669287|t=2020. Comprehensive mapping of immune perturbations associated with severe COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32651212|t=2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.|pdf=|usr=014}}
  
 +
{{tp|p=32679910|t=2020. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.|pdf=|usr=014}}
 +
{{tp|p=32678072|t=2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.|pdf=|usr=014}}
 +
{{tp|p=32694615|t=2020. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.|pdf=|usr=014}}
 +
{{tp|p=32715628|t=2020. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?|pdf=|usr=014}}
 +
{{tp|p=32715618|t=2020. The protein expression profile of ACE2 in human tissues.|pdf=|usr=014}}
 +
{{tp|p=32669467|t=2020. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32694127|t=2020. COVID-19 and the Gut Microbiome: More than a Gut Feeling.|pdf=|usr=014}}
 +
{{tp|p=32681106|t=2020. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.|pdf=|usr=014}}
 +
{{tp|p=32665645|t=2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.|pdf=|usr=014}}
 +
{{tp|p=32686754|t=2020. Antibody responses to SARS-CoV-2 short-lived.|pdf=|usr=014}}
 +
{{tp|p=32686753|t=2020. Virus dissociated from inflammation in fatal COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32651570|t=2020. CRISPRing for host genes regulating SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32651569|t=2020. SARS-CoV-2 on the neural battleground.|pdf=|usr=014}}
 +
{{tp|p=32651568|t=2020. T cell renaissance in COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32690876|t=2020. Can COVID-19 strike twice?|pdf=|usr=014}}
 +
{{tp|p=32699357|t=2020. COVID-19 management in light of the circadian clock.|pdf=|usr=014}}
 +
{{tp|p=32668692|t=2020. Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.|pdf=|usr=014}}
 +
{{tp|p=32691391|t=2020. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.|pdf=|usr=014}}
 +
{{tp|p=32665786|t=2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.|pdf=|usr=014}}
 +
{{tp|p=32685291|t=2020. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.|pdf=|usr=014}}
 +
{{tp|p=32659343|t=2020. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.|pdf=|usr=014}}
 +
{{tp|p=32671793|t=2020. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.|pdf=|usr=014}}
 +
{{tp|p=32651900|t=2020. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology.|pdf=|usr=014}}
 +
{{tp|p=32611518|t=2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.|pdf=|usr=014}}
 +
{{tp|p=32704472|t=2020. Hemophagocytic syndrome and COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32664949|t=2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.|pdf=|usr=014}}
 +
{{tp|p=32704018|t=2020. Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames.|pdf=|usr=014}}
 +
{{tp|p=32691370|t=2020. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.|pdf=|usr=014}}
 +
{{tp|p=32702413|t=2020. Multisystem Inflammatory Syndrome in Children: Is There a Linkage to Kawasaki Disease?|pdf=|usr=014}}
 +
{{tp|p=32653566|t=2020. Understanding The Complex Relationship Between Androgens and SARS-CoV2.|pdf=|usr=014}}
 +
{{tp|p=32679691|t=2020. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.|pdf=|usr=014}}
 +
{{tp|p=32666230|t=2020. Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.|pdf=|usr=014}}
 +
{{tp|p=32699972|t=2020. Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19.|pdf=|usr=014}}
 +
{{tp|p=32687861|t=2020. Phylogenetic and phylodynamic analyses of SARS-CoV-2.|pdf=|usr=014}}
 +
{{tp|p=32674515|t=2020. Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.|pdf=|usr=014}}
 +
{{tp|p=32614178|t=2020. Pulmonary Edema in COVID19-A Neural Hypothesis.|pdf=|usr=012}}
 +
{{tp|p=32638079|t=2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32628642|t=2020. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.|pdf=|usr=012}}
 +
{{tp|p=32650004|t=2020. Eicosanoids: the Overlooked Storm in COVID-19?|pdf=|usr=012}}
 +
{{tp|p=32628931|t=2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.|pdf=|usr=012}}
 +
{{tp|p=32639866|t=2020. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.|pdf=|usr=012}}
 +
{{tp|p=32622243|t=2020. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.|pdf=|usr=012}}
 +
{{tp|p=32611313|t=2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.|pdf=|usr=012}}
 +
{{tp|p=32629042|t=2020. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.|pdf=|usr=012}}
 +
{{tp|p=32646930|t=2020. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.|pdf=|usr=012}}
 +
{{tp|p=32645391|t=2020. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.|pdf=|usr=012}}
 +
{{tp|p=32646523|t=2020. Adrenomedullin in COVID-19 induced endotheliitis.|pdf=|usr=012}}
 +
{{tp|p=32643351|t=2020. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.|pdf=|usr=012}}
 +
{{tp|p=32640417|t=2020. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.|pdf=|usr=012}}
 +
{{tp|p=32610564|t=2020. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.|pdf=|usr=012}}
 +
{{tp|p=32646736|t=2020. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.|pdf=|usr=012}}
 +
{{tp|p=32650275|t=2020. Reappearance of effector T cells is associated with recovery from COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32629393|t=2020. Illuminating COVID-19 lung disease through autopsy studies.|pdf=|usr=012}}
 +
{{tp|p=32632419|t=2020. Eosinopenia and COVID-19 patients: So specific ?|pdf=|usr=012}}
 +
{{tp|p=32633718|t=2020. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.|pdf=|usr=012}}
 +
{{tp|p=32614767|t=2020. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.|pdf=|usr=012}}
 +
{{tp|p=32618497|t=2020. High neutralizing antibody titer in intensive care unit patients with COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32620946|t=2020. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.|pdf=|usr=012}}
 +
{{tp|p=32615182|t=2020. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.|pdf=|usr=012}}
 +
{{tp|p=32634438|t=2020. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.|pdf=|usr=012}}
 +
{{tp|p=32631841|t=2020. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.|pdf=|usr=012}}
 +
{{tp|p=32631838|t=2020. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.|pdf=|usr=012}}
 +
{{tp|p=32631836|t=2020. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?|pdf=|usr=012}}
 +
{{tp|p=32646049|t=2020. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.|pdf=|usr=012}}
 +
{{tp|p=32646047|t=2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.|pdf=|usr=012}}
 +
{{tp|p=32645523|t=2020. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.|pdf=|usr=012}}
 +
{{tp|p=32640274|t=2020. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.|pdf=|usr=012}}
 +
{{tp|p=32641873|t=2020. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.|pdf=|usr=012}}
 +
{{tp|p=32621172|t=2020. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.|pdf=|usr=012}}
 +
{{tp|p=32615316|t=2020. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.|pdf=|usr=012}}
 +
{{tp|p=32622082|t=2020. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.|pdf=|usr=012}}
 +
{{tp|p=32638151|t=2020. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.|pdf=|usr=012}}
 +
{{tp|p=32634585|t=2020. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32613447|t=2020. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.|pdf=|usr=012}}
 +
{{tp|p=32630032|t=2020. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.|pdf=|usr=012}}
 +
{{tp|p=32629995|t=2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32645951|t=2020. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.|pdf=|usr=012}}
 +
{{tp|p=32640747|t=2020. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.|pdf=|usr=012}}
 +
{{tp|p=32621017|t=2020. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.|pdf=|usr=012}}
 +
{{tp|p=32642784|t=2020. Serum antibody response in critically ill patients with COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32624257|t=2020. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.|pdf=|usr=012}}
 +
{{tp|p=32615258|t=2020. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.|pdf=|usr=012}}
 +
{{tp|p=32639084|t=2020. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.|pdf=|usr=012}}
 +
{{tp|p=32634129|t=2020. Kinetics of viral load and antibody response in relation to COVID-19 severity.|pdf=|usr=012}}
 +
{{tp|p=32610587|t=2020. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.|pdf=|usr=012}}
 +
{{tp|p=32635302|t=2020. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.|pdf=|usr=012}}
 +
{{tp|p=32645361|t=2020. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.|pdf=|usr=012}}
 +
{{tp|p=32615199|t=2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.|pdf=|usr=012}}
 +
{{tp|p=32622905|t=2020. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.|pdf=|usr=012}}
 +
{{tp|p=32614392|t=2020. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.|pdf=|usr=012}}
 +
{{tp|p=32647285|t=2020. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.|pdf=|usr=012}}
 +
{{tp|p=32645344|t=2020. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.|pdf=|usr=012}}
 +
{{tp|p=32645661|t=2020. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?|pdf=|usr=012}}
 +
{{tp|p=32645660|t=2020. Is macrophages heterogeneity important in determining COVID-19 lethality?|pdf=|usr=012}}
 +
{{tp|p=32650197|t=2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.|pdf=|usr=012}}
 +
{{tp|p=32645659|t=2020. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.|pdf=|usr=012}}
 +
{{tp|p=32646911|t=2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.|pdf=|usr=012}}
 +
{{tp|p=32646908|t=2020. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.|pdf=|usr=012}}
 +
{{tp|p=32641700|t=2020. Immunological and inflammatory profiles in mild and severe cases of COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32641705|t=2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.|pdf=|usr=012}}
 +
{{tp|p=32648040|t=2020. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.|pdf=|usr=012}}
 +
{{tp|p=32642842|t=2020. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.|pdf=|usr=012}}
 +
{{tp|p=32627524|t=2020. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.|pdf=|usr=012}}
 +
{{tp|p=32650002|t=2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.|pdf=|usr=012}}
 +
{{tp|p=32631071|t=2020. COVID-ARDS Clarified: A Vascular Endotype?|pdf=|usr=012}}
 +
{{tp|p=32649217|t=2020. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32608999|t=2020. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.|pdf=|usr=012}}
 +
{{tp|p=32628534|t=2020. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.|pdf=|usr=012}}
 +
{{tp|p=32633104|t=2020. Covid-19 related IgA vasculitis.|pdf=|usr=012}}
 +
{{tp|p=32636189|t=2020. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.|pdf=|usr=012}}
 +
{{tp|p=32643798|t=2020. Tackling COVID-19 infection through complement-targeted immunotherapy.|pdf=|usr=012}}
 +
{{tp|p=32640169|t=2020. Potential impact of SARS-CoV-2 infection on the thymus.|pdf=|usr=012}}
 +
{{tp|p=32641195|t=2020. Reply to the letter concerning Kawasaki Disease and Covid-19.|pdf=|usr=012}}
 +
{{tp|p=32638018|t=2020. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.|pdf=|usr=012}}
 +
{{tp|p=32636454|t=2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.|pdf=|usr=012}}
 +
{{tp|p=32639942|t=2020. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.|pdf=|usr=012}}
 +
{{tp|p=32639941|t=2020. The early antibody response to SARS-Cov-2 infection.|pdf=|usr=012}}
 +
{{tp|p=32638022|t=2020. Direct evidence of active SARS-CoV-2 replication in the intestine.|pdf=|usr=012}}
 +
{{tp|p=32645713|t=2020. Microbiota and Covid-19. Which came first, the chicken or the egg?|pdf=|usr=012}}
 +
{{tp|p=32645228|t=2020. Angiotensin II Receptors - Impact for COVID-19 Severity.|pdf=|usr=012}}
 +
{{tp|p=32631463|t=2020. COVID-19: Yin and Yang and Herd Immunity.|pdf=|usr=012}}
 +
{{tp|p=32645207|t=2020. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.|pdf=|usr=012}}
 +
{{tp|p=32635753|t=2020. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=012}}
 +
{{tp|p=32614086|t=2020. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.|pdf=|usr=012}}
 +
{{tp|p=32629518|t=2020. Inflammatory Cell Infiltration of Adrenals in COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32643416|t=2020. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.|pdf=|usr=012}}
 +
{{tp|p=32615317|t=2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.|pdf=|usr=012}}
 +
{{tp|p=32624498|t=2020. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.|pdf=|usr=012}}
 +
{{tp|p=32643586|t=2020. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.|pdf=|usr=012}}
 +
{{tp|p=32639183|t=2020. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.|pdf=|usr=012}}
 +
{{tp|p=32640487|t=2020. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.|pdf=|usr=012}}
 +
{{tp|p=32644266|t=2020. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.|pdf=|usr=012}}
 +
{{tp|p=32644223|t=2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.|pdf=|usr=012}}
 +
{{tp|p=32639581|t=2020. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.|pdf=|usr=012}}
 +
{{tp|p=32633840|t=2020. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).|pdf=|usr=012}}
 +
{{tp|p=32633815|t=2020. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.|pdf=|usr=012}}
 +
{{tp|p=32642770|t=2020. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.|pdf=|usr=012}}
 +
{{tp|p=32640066|t=2020. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.|pdf=|usr=012}}
 +
{{tp|p=32641486|t=2020. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.|pdf=|usr=012}}
 +
{{tp|p=32622377|t=2020. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?|pdf=|usr=012}}
 +
{{tp|p=32611256|t=2020. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.|pdf=|usr=012}}
 +
{{tp|p=32640127|t=2020. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.|pdf=|usr=012}}
 +
{{tp|p=32641847|t=2020. A COVID-19 model.|pdf=|usr=012}}
 +
{{tp|p=32647358|t=2020. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.|pdf=|usr=012}}
 +
{{tp|p=32647346|t=2020. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.|pdf=|usr=012}}
 +
{{tp|p=32616673|t=2020. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.|pdf=|usr=012}}
 +
{{tp|p=32638509|t=2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.|pdf=|usr=012}}
  
===integrative work===
+
{{tp|p=32611670|t=2020. Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues.|pdf=|usr=012}}
*[https://www.cell.com/action/showPdf?pii=S1074-7613%2820%2930183-7 rev. on covid immunology]
+
{{tp|p=32627126|t=2020. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?|pdf=|usr=012}}
{{tp|p=32205856|t=2020. COVID-19 infection: the perspectives on immune responses |pdf=|usr=}}
+
{{tp|p=32641482|t=2020. LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.|pdf=|usr=012}}
{{tp|p=32359396|t=ä. A Dynamic Immune Response Shapes COVID-19 Progression |pdf=|usr=}}
+
{{tp|p=32622376|t=2020. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.|pdf=|usr=012}}
{{tp|p=C7064018|t=ä. Coronavirus infections: Epidemiological, clinical and immunological features and  hypotheses |pdf=|usr=}}
+
{{tp|p=32619412|t=2020. Endothelial cells orchestrate COVID-19 coagulopathy.|pdf=|usr=012}}
{{ttp|p=C7200337|t=ä. Immunology of COVID-19: current state of the science |pdf=|usr=}}
+
{{tp|p=32619411|t=2020. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.|pdf=|usr=012}}
{{tp|p=32505227|t=2020. Immunology of COVID-19: Current State of the Science.|pdf=|usr=007}}
+
{{tp|p=32616514|t=2020. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.|pdf=|usr=012}}
{{tp|p=32469225|t=2020. COVID-19 and the immune system.|pdf=|usr=007}}
+
{{tp|p=32629204|t=2020. A hypothesis on the role of the human immune system in covid-19.|pdf=|usr=012}}
{{ttp|p=32436629|t=2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.|pdf=|usr=007}}
+
{{tp|p=32622045|t=2020. Integrated Approaches to Reveal Mechanisms by which RNA Viruses Reprogram the Cellular Environment.|pdf=|usr=012}}
{{tp|p=32507543|t=2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.|pdf=|usr=007}}
+
{{tp|p=32616647|t=2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco.|pdf=|usr=012}}
{{ttp|p=32504757|t=2020. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.|pdf=|usr=007}}
+
{{tp|p=32616644|t=2020. Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019.|pdf=|usr=012}}
{{tp|p=32493812|t=2020. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.|pdf=|usr=007}}
+
{{tp|p=32620916|t=2020. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection.|pdf=|usr=012}}
{{tp|p=32470151|t=2020. The perplexing question of trained immunity versus adaptive memory in COVID-19.|pdf=|usr=007}}
+
{{tp|p=32632085|t=2020. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.|pdf=|usr=012}}
{{tp|p=32472706|t=2020. The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.|pdf=|usr=007}}
+
{{tp|p=32612128|t=2020. High-altitude populations need special considerations for COVID-19.|pdf=|usr=012}}
{{tp|p=32213336|t=ä. SARS-CoV-2: virus dynamics and host response |pdf=|usr=}}
+
{{tp|p=32636479|t=2020. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.|pdf=|usr=012}}
{{tp|p=32437933|t=2020. Viral dynamics in asymptomatic patients with COVID-19.|pdf=|usr=008}}
+
{{tp|p=32636475|t=2020. SARS-CoV-2-specific T cells without antibodies.|pdf=|usr=012}}
{{tp|p=32407836|t=2020. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.|pdf=|usr=008}}
+
{{tp|p=32629960|t=2020. Evidence for SARS-CoV-2 Infection of Animal Hosts.|pdf=|usr=012}}
{{tp|p=32498686|t=2020. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
+
{{tp|p=32640525|t=2020. Molecular Aspects of COVID-19 Differential Pathogenesis.|pdf=|usr=012}}
{{tp|p=32514817|t=2020. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.|pdf=|usr=008}}
+
{{tp|p=32627515|t=2020. Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.|pdf=|usr=012}}
{{tp|p=32460144|t=2020. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions.|pdf=|usr=008}}
+
{{tp|p=32638966|t=2020. Immunological aspects of coronavirus disease during pregnancy: an integrative review.|pdf=|usr=012}}
{{tp|p=32417709|t=2020. Mechanism of inflammatory response in associated comorbidities in COVID-19.|pdf=|usr=008}}
+
{{tp|p=32621057|t=2020. The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.|pdf=|usr=012}}
{{tp|p=32444400|t=2020. COVID-19 and the nicotinic cholinergic system.|pdf=|usr=008}}
+
{{tp|p=32616709|t=2020. Mapping the T cell response to COVID-19.|pdf=|usr=012}}
{{tp|p=32413330|t=2020. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.|pdf=|usr=008}}
+
{{tp|p=32619819|t=2020. S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study.|pdf=|usr=012}}
{{tp|p=32514174|t=2020. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.|pdf=|usr=008}}
+
{{tp|p=32615987|t=2020. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.|pdf=|usr=012}}
{{tp|p=32489708|t=2020. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
+
{{tp|p=32396996|t=2020. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.|pdf=|usr=008}}
+
{{ttp|p=32454136|t=2020. The role of IgA in COVID-19.|pdf=|usr=008}}
+
{{ttp|p=32526273|t=2020. A plea for the pathogenic role of immune complexes in severe Covid-19.|pdf=|usr=008}}
+
{{tp|p=32502542|t=2020. The immune system and COVID-19: Friend or foe?|pdf=|usr=009}}
+
{{tp|p=32505066|t=2020. COVID-19: Loss of bridging between innate and adaptive immunity?|pdf=|usr=009}}
+
{{tp|p=32461671|t=2020. Innate T cells in COVID-19: friend or foe?|pdf=|usr=009}}
+
{{tp|p=32533292|t=2020. Targeting the immunology of coronavirus disease-19: synchronization creates symphony.|pdf=|usr=009}}
+
{{tp|p=32445403|t=2020. SARS-CoV-2 infection-induced immune responses: Friends or foes?|pdf=|usr=009}}
+
{{tp|p=32510470|t=2020. Is innate immunity our best weapon for flattening the curve?|pdf=|usr=008}}
+
{{tp|p=32574709|t=2020. COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential.|pdf=|usr=010}}
+
{{tp|p=32578831|t=2020. Human Leukocyte Transcriptional Response to SARS-CoV-2 Infection.|pdf=|usr=010}}
+
{{tp|p=32584441|t=2020. Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives - a report of the European Academy of Allergy and Clinical Immunology (EAACI).|pdf=|usr=010}}
+
{{tp|p=32592406|t=2020. Immune response in children with COVID-19 is characterized by lower levels of T cell activation than infected adults.|pdf=|usr=010}}
+
{{ttp|p=32579268|t=2020. SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.|pdf=|usr=011}}
+
{{tp|p=32591408|t=2020. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.|pdf=|usr=011}}
+
{{tp|p=32576386|t=2020. Deciphering the TCR Repertoire to Solve the COVID-19 Mystery.|pdf=|usr=011}}
+
{{tp|p=32582743|t=2020. Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.|pdf=|usr=011}}
+
 
+
 
+
 
+
===covid modulates the immune system===
+
{{ttp|p=32514047|t=2020. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).|pdf=|usr=008}}
+
{{ttp|p=32479746|t=2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.|pdf=|usr=008}}
+
{{ttp|p=32529952|t=2020. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.|pdf=|usr=008}}
+
{{tp|p=32364527|t=2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2 |pdf=|usr=}}
+
{{tp|p=32172672|t=2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |pdf=|usr=}}
+
{{tp|p=32315725|t=ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China |pdf=|usr=}}
+
{{ttp|p=32355328|t=ä. Impaired interferon signature in severe COVID-19 |pdf=|usr=}}
+
{{tp|p=32375560|t=2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study |pdf=|usr=}}
+
{{tp|p=32376308|t=ä. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis |pdf=|usr=}}
+
{{ttp|p=32236983|t=2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection |pdf=|usr=}}
+
{{ttp|p=32286536|t=ä. Coronaviruses hijack the complement system |pdf=|usr=}}''host complement activator MASP2 as a target of the N protein of all three viruses''
+
{{tp|p=32463803|t=2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.|pdf=|usr=007}}
+
{{tp|p=32492165|t=2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.|pdf=|usr=007}}
+
{{tp|p=32514592|t=2020. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.|pdf=|usr=008}}
+
{{tp|p=32456696|t=2020. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients.|pdf=|usr=008}}
+
{{tp|p=32502135|t=2020. Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.|pdf=|usr=008}}
+
{{tp|p=32532524|t=2020. SARS-CoV-2-A Tough Opponent for the Immune System.|pdf=|usr=008}}
+
{{tp|p=32416070|t=2020. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.|pdf=|usr=008}}
+
{{tp|p=32513989|t=2020. The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.|pdf=|usr=008}}
+
{{tp|p=32409741|t=2020. Modulation of immune crosstalk in COVID-19.|pdf=|usr=009}}
+
{{tp|p=32504059|t=2020. Many paths to COVID-19 lymphocyte dysfunction.|pdf=|usr=009}}
+
{{tp|p=32528136|t=2020. Considering how biological sex impacts immune responses and COVID-19 outcomes.|pdf=|usr=009}}
+
{{tp|p=32587367|t=2020. Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients.|pdf=|usr=010}}
+
{{tp|p=32554697|t=2020. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.|pdf=|usr=011}}
+
 
+
 
+
===immune cell subpopulations===
+
{{tp|p=32282871|t=ä. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
+
{{tp|p=32325421|t=2020. Increased expression of CD8 marker on T-cells in COVID-19 patients |pdf=|usr=}}
+
{{tp|p=32377375|t=2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing |pdf=|usr=}}
+
{{tp|p=32346099|t=ä. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients |pdf=|usr=}}
+
{{tp|p=32339487|t=2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China |pdf=|usr=}}
+
{{tp|p=32361250|t=2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients |pdf=|usr=}}
+
{{tp|p=32228226|t=2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients |pdf=|usr=}}
+
{{tp|p=32196410|t=2020. Hypothesis for potential pathogenesis of SARS-CoV-2 infection?a review of immune  changes in patients with viral pneumonia |pdf=|usr=}}
+
{{tp|p=32333914|t=ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia |pdf=|usr=}}
+
{{tp|p=32344320|t=ä. The clinical course and its correlated immune status in COVID-19 pneumonia |pdf=|usr=}}
+
{{tp|p=32325129|t=ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia |pdf=|usr=}}
+
{{tp|p=32283159|t=ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19 |pdf=|usr=}}
+
{{tp|p=32227123|t=ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia |pdf=|usr=}}
+
{{tp|p=32343510|t=2020. COVID-19: are T lymphocytes simply watching?|pdf=|usr=}}
+
{{tp|p=32379887|t=ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19 |pdf=|usr=}}
+
{{tp|p=32297671|t=2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients |pdf=|usr=}}
+
{{tp|p=32352397|t=2020. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study |pdf=|usr=}}
+
{{tp|p=32379199|t=2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes |pdf=|usr=}}
+
{{tp|p=32296069|t=2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study |pdf=|usr=}}
+
{{tp|p=32407057|t=2020. Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series.|pdf=|usr=007}}
+
{{tp|p=32297828|t=2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19 |pdf=|usr=}}
+
{{tp|p=32370466|t=2020.  Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19  |pdf=|usr=}}
+
{{tp|p=32114745|t=2020.  Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19  |pdf=|usr=}}
+
{{tp|p=32377375|t=2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing |pdf=|usr=}}
+
{{tp|p=32361250|t=2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients |pdf=|usr=}}
+
{{ttp|p=32376308|t=2020. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis |pdf=|usr=}}
+
{{tp|p=32458561|t=2020. Lymphopenia in COVID-19: Therapeutic opportunities.|pdf=|usr=007}}
+
{{tp|p=32420610|t=2020. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.|pdf=|usr=007}}
+
{{tp|p=32470153|t=2020. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.|pdf=|usr=007}}
+
{{tp|p=32474608|t=2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.|pdf=|usr=007}}
+
{{tp|p=32483488|t=2020. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.|pdf=|usr=008}}
+
{{tp|p=32382776|t=2020. Signals of Th2 immune response from COVID-19 patients requiring intensive care.|pdf=|usr=008}}
+
{{tp|p=32417210|t=2020. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?|pdf=|usr=008}}
+
{{tp|p=32405080|t=2020. Decreased T cell populations contribute to the increased severity of COVID-19.|pdf=|usr=008}}
+
{{tp|p=32407466|t=2020. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.|pdf=|usr=008}}
+
{{tp|p=32569607|t=2020. Lymphopenia during the COVID-19 infection: What it shows and what can be learned.|pdf=|usr=010}}
+
{{tp|p=32543971|t=2020. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.|pdf=|usr=010}}
+
{{tp|p=32598880|t=2020. Less expression of CD4(+) and CD8(+) T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: Evidence from a pooled analysis.|pdf=|usr=011}}
+
{{tp|p=32569604|t=2020. CD4+T, CD8+T counts and severe COVID-19: A meta-analysis.|pdf=|usr=011}}
+
{{tp|p=32608572|t=2020. Peripheral lymphocyte subset alterations in COVID-19 patients.|pdf=|usr=011}}
+
 
+
 
+
===t cell exhaustion===
+
{{tp|p=32249845|t=ä. Fighting COVID-19 exhausts T cells |pdf=|usr=}}
+
{{tp|p=32479985|t=2020. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.|pdf=|usr=008}}
+
{{ttp|p=32203188|t=ä. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |pdf=|usr=}}
+
{{ttp|p=32203186|t=ä. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |pdf=|usr=}}
+
{{ttp|p=32203188|t=2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |pdf=|usr=}}
+
{{ttp|p=32203186|t=2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |pdf=|usr=}}
+
{{tp|p=32414395|t=2020. COVID-19: room for treating T cell exhaustion?|pdf=|usr=008}}
+
{{tp|p=32425950|t=2020. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
+
{{tp|p=32539816|t=2020. Response to "COVID-19: room for treating T cell exhaustion?"|pdf=|usr=010}}
+
 
+
 
+
 
+
===nk cells===
+
{{tp|p=32382127|t=ä. NKG2A and COVID-19: another brick in the wall |pdf=|usr=}}
+
{{tp|p=32344314|t=2020. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents |pdf=|usr=}}
+
 
+
 
+
===plasmacytoid dendritic cells===
+
{{tp|p=32298486|t=2020. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19) |pdf=|usr=}}
+
 
+
 
+
===antiviral immune response===
+
{{tp|p=32280952|t=ä. Good IgA bad IgG in SARS-CoV-2 infection?|pdf=|usr=}}
+
{{tp|p=32353870|t=2020. The many faces of the anti-COVID immune response |pdf=|usr=}}
+
{{tp|p=32358956|t=ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19 |pdf=|usr=}}
+
{{tp|p=31981224|t=2020. Coronavirus infections and immune responses |pdf=|usr=}}
+
{{tp|p=32198005|t=2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course  and anti-SARS-CoV-2 IgG dynamic |pdf=|usr=}}
+
{{tp|p=32284614|t=ä. Breadth of concomitant immune responses prior to patient recovery: a case report  of non-severe COVID-19 |pdf=|usr=}}
+
{{tp|p=32355329|t=ä. SARS-CoV-2-reactive T cells in patients and healthy donors |pdf=|usr=}}
+
{{tp|p=32346091|t=ä. Neutralizing antibody response in mild COVID-19 |pdf=|usr=}}
+
{{tp|p=32356908|t=2020. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis |pdf=|usr=}}
+
{{ttp|p=32343415|t=2020. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients |pdf=|usr=}}
+
{{tp|p=32330332|t=2020. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic |pdf=|usr=}}
+
{{tp|p=32267987|t=2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS |pdf=|usr=}}
+
{{tp|p=32348715|t=2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020 |pdf=|usr=}}
+
{{tp|p=32382126|t=ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients |pdf=|usr=}}
+
{{tp|p=32200654|t=2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus  Infection |pdf=|usr=}}
+
{{tp|p=32476607|t=2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.|pdf=|usr=007}}
+
{{tp|p=32449333|t=2020. (+)Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.|pdf=|usr=007}}
+
{{tp|p=32430094|t=2020. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.|pdf=|usr=007}}
+
{{tp|p=32467617|t=2020. Serum IgA, IgM, and IgG responses in COVID-19.|pdf=|usr=007}}
+
{{ttp|p=32467616|t=2020. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells.|pdf=|usr=007}}
+
{{ttp|p=32463434|t=2020. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.|pdf=|usr=007}}
+
{{tp|p=32398307|t=2020. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.|pdf=|usr=008}}
+
{{tp|p=32425634|t=2020. The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection.|pdf=|usr=008}}
+
{{tp|p=32383183|t=2020. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.|pdf=|usr=008}}{{tp|p=32521002|t=2020. Antibody profiles in mild and severe cases of COVID-19.|pdf=|usr=008}}
+
{{tp|p=32399213|t=2020. Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.|pdf=|usr=008}}
+
{{tp|p=32515684|t=2020. Patterns of IgG and IgM antibody response in COVID-19 patients.|pdf=|usr=008}}
+
{{ttp|p=32425955|t=2020. Potential SARS-CoV-2 Preimmune IgM Epitopes.|pdf=|usr=008}}
+
{{tp|p=32439770|t=2020. T cells found in coronavirus patients 'bode well' for long-term immunity.|pdf=|usr=008}}
+
{{ttp|p=32473127|t=2020. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.|pdf=|usr=008}}
+
{{tp|p=32513850|t=2020. Early Insights into Immune Responses during COVID-19.|pdf=|usr=008}}
+
{{tp|p=32544611|t=2020. Development of child immunity in the context of COVID-19 pandemic.|pdf=|usr=011}}
+
{{tp|p=32572527|t=2020. SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients.|pdf=|usr=010}}
+
{{tp|p=32607314|t=2020. Assessing Immune Response to SARS-CoV-2 Infection.|pdf=|usr=011}}
+
{{tp|p=32574261|t=2020. Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art.|pdf=|usr=011}}
+
 
+
 
+
===antiviral mediators===
+
{{tp|p=32422144|t=2020. Perforin and resistance to SARS coronavirus 2.|pdf=|usr=008}}
+
{{ttp|p=32437749|t=2020. Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.|pdf=|usr=008}}
+
 
+
 
+
===mediators===
+
{{tp|p=32360285|t=ä. Type I IFN immunoprofiling in COVID-19 patients |pdf=|usr=}}
+
{{ttp|p=32376393|t=ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |pdf=|usr=}}
+
{{ttp|p=32305501|t=ä. The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement |pdf=|usr=}}
+
{{tp|p=30715745|t=2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study |pdf=|usr=}}
+
{{tp|p=32414693|t=2020. Interleukin-6 levels in children developing SARS-CoV-2 infection |pdf=|usr=}}
+
{{ttp|p=32421281|t=2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?|pdf=|usr=007}}
+
{{tp|p=32437622|t=2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.|pdf=|usr=007}}
+
{{tp|p=32475759|t=2020. IL-6: Relevance for immunopathology of SARS-CoV-2.|pdf=|usr=008}}
+
{{tp|p=32457522|t=2020. Dysregulation of type I interferon responses in COVID-19.|pdf=|usr=009}}
+
{{tp|p=32435059|t=2020. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.|pdf=|usr=009}}
+
{{tp|p=32464309|t=2020. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients.|pdf=|usr=008}}
+
{{tp|p=32553163|t=2020. Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins.|pdf=|usr=010}}
+
{{tp|p=32579952|t=2020. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?|pdf=|usr=011}}
+
{{tp|p=32540458|t=2020. Elevated nucleoprotein-induced interferon-gamma release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay.|pdf=|usr=011}}
+
{{tp|p=32563194|t=2020. Serum Cytokine and Chemokine profile in Relation to the Severity of Coronavirus disease 2019 (COVID-19) in China.|pdf=|usr=011}}
+
{{ttp|p=32595654|t=2020. Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells.|pdf=|usr=011}}
+
{{tp|p=32574271|t=2020. The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria.|pdf=|usr=011}}
+
 
+
 
+
 
+
===immunopathology===
+
{{tp|p=32371101|t=ä. The correlation between SARS-CoV-2 infection and rheumatic disease |pdf=|usr=}}
+
{{tp|p=32205186|t=2020. COVID-19 infection and rheumatoid arthritis: Faraway, so close!|pdf=|usr=}}
+
{{tp|p=32308263|t=2020. CoViD-19 Immunopathology and Immunotherapy |pdf=|usr=}}
+
{{tp|p=32320677|t=ä. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure |pdf=|usr=}}
+
{{tp|p=32161940|t=ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China |pdf=|usr=}}
+
{{tp|p=32282863|t=ä. Molecular immune pathogenesis and diagnosis of COVID-19 |pdf=|usr=}}
+
{{tp|p=32321823|t=2020. COVID-19: an Immunopathological View |pdf=|usr=}}
+
{{tp|p=32273594|t=ä. COVID-19: immunopathology and its implications for therapy |pdf=|usr=}}
+
{{tp|p=32303696|t=ä. Macrophages: a Trojan horse in COVID-19?|pdf=|usr=}}
+
{{ttp|p=32376901|t=ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages |pdf=|usr=}}
+
{{tp|p=32423059|t=2020. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.|pdf=|usr=007}}
+
{{tp|p=32485101|t=2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.|pdf=|usr=007}}
+
{{tp|p=32423917|t=2020. COVID-19 as an Acute Inflammatory Disease.|pdf=|usr=007}}
+
{{ttp|p=32512289|t=2020. Neutralizing antibodies mediate virus-immune pathology of COVID-19.|pdf=|usr=007}}
+
{{tp|p=32398875|t=2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.|pdf=|usr=007}}
+
{{tp|p=32391668|t=2020. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].|pdf=|usr=007}}
+
{{ttp|p=32498376|t=2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.|pdf=|usr=007}}
+
{{tp|p=32460357|t=2020. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.|pdf=|usr=007}}
+
{{ttp|p=32492530|t=2020. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.|pdf=|usr=008}}
+
{{tp|p=32389590|t=2020. COVID-19: Unanswered questions on immune response and pathogenesis.|pdf=|usr=008}}
+
{{tp|p=32422146|t=2020. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.|pdf=|usr=008}}
+
{{tp|p=32521376|t=2020. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.|pdf=|usr=008}}
+
{{tp|p=32470851|t=2020. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis.|pdf=|usr=008}}
+
{{tp|p=32454103|t=2020. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection.|pdf=|usr=008}}
+
{{tp|p=32398804|t=2020. Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?|pdf=|usr=008}}
+
{{tp|p=32466999|t=2020. COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?|pdf=|usr=009}}
+
{{tp|p=32581077|t=2020. COVID-19 Hyperinflammation: What about Neutrophils?|pdf=|usr=010}}
+
{{tp|p=32582303|t=2020. Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study.|pdf=|usr=011}}
+
{{tp|p=32543740|t=2020. Dysregulation of the immune response affects the outcome of critical COVID-19 patients.|pdf=|usr=011}}
+
{{tp|p=32573711|t=2020. Platelet Gene Expression and Function in COVID-19 Patients.|pdf=|usr=010}}
+
{{tp|p=32579477|t=2020. Platelets and Immunity: Going Viral.|pdf=|usr=010}}
+
{{tp|p=32545714|t=2020. Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.|pdf=|usr=011}}
+
{{tp|p=32591762|t=2020. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.|pdf=|usr=010}}
+
{{tp|p=32584597|t=2020. Characterization of the Inflammatory Response to Severe COVID-19 Illness.|pdf=|usr=011}}
+
{{tp|p=32574260|t=2020. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.|pdf=|usr=011}}
+
 
+
===secondary autoimmunity===
+
{{tp|p=32292901|t=2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity |pdf=|usr=}}
+
{{tp|p=32220633|t=2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?|pdf=|usr=}}
+
{{tp|p=32315487|t=2020. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19 |pdf=|usr=}}
+
{{ttp|p=32314313|t=2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?|pdf=|usr=}}
+
{{tp|p=32389543|t=ä. COVID-19 and molecular mimicry: The Columbus? egg?|pdf=|usr=}}
+
{{tp|p=32444414|t=2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.|pdf=|usr=007}}
+
{{ttp|p=32535095|t=2020. Molecular mimicry may explain multi-organ damage in COVID-19.|pdf=|usr=008}}
+
{{tp|p=32535093|t=2020. Covid-19 and autoimmunity.|pdf=|usr=008}}
+
{{tp|p=32461193|t=2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.|pdf=|usr=008}}
+
{{tp|p=32504061|t=2020. SARS-CoV-2 cross-reactivity in healthy donors.|pdf=|usr=009}}
+
{{tp|p=32387238|t=2020. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?|pdf=|usr=009}}
+
{{tp|p=32563547|t=2020. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.|pdf=|usr=011}}
+
 
+
 
+
===Thymus===
+
{{tp|p=32340873|t=ä. Reply: Thymopoiesis, inflamm-aging, and COVID-19 phenotype |pdf=|usr=}}
+
{{tp|p=32317217|t=ä. Role of thymopoiesis and inflamm-aging in COVID-19 phenotype |pdf=|usr=}}
+
 
+
 
+
===Eosinopenia, Eosinophilia===
+
{{tp|p=32368728|t=ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study |pdf=|usr=}}
+
{{tp|p=32344056|t=ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination |pdf=|usr=}}
+
{{tp|p=32369190|t=2020. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series |pdf=|usr=}}
+
{{ttp|p=32315429|t=ä. Eosinophil count in severe coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
+
{{tp|p=32315421|t=ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
+
{{tp|p=32390402|t=2020. SARS-CoV-2 and Eosinophilia.|pdf=|usr=007}}
+
{{tp|p=32544911|t=2020. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.|pdf=|usr=010}}
+
{{tp|p=32540792|t=2020. Eosinophil Response Against Classical and Emerging Respiratory Viruses: COVID-19.|pdf=|usr=010}}
+
{{tp|p=32572245|t=2020. Roles for eosinophils and basophils in COVID-19?|pdf=|usr=010}}
+
 
+
===Immunosenescence===
+
{{tp|p=32597792|t=2020. Reversing immunosenescence for prevention of COVID-19.|pdf=|usr=011}}
+
{{tp|p=32583231|t=2020. Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity.|pdf=|usr=010}}
+
{{tp|p=32556942|t=2020. Severe COVID-19 and aging: are monocytes the key?|pdf=|usr=010}}
+
{{tp|p=32544216|t=2020. COVID-19 and Crosstalk With the Hallmarks of Aging.|pdf=|usr=010}}
+
{{tp|p=32489698|t=2020. COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.|pdf=|usr=008}}
+
 
+
 
+
===microbiome===
+
{{tp|p=32497191|t=2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.|pdf=|usr=007}}
+
{{ttp|p=32426999|t=2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.|pdf=|usr=007}}
+
{{tp|p=32432790|t=2020. Editorial - COVID-19 and the microbiota: new kids on the block.|pdf=|usr=008}}
+
{{tp|p=32442562|t=2020. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.|pdf=|usr=008}}
+
{{ttp|p=32579014|t=2020. Systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19.|pdf=|usr=010}}
+
{{tp|p=32552848|t=2020. Compassionate use of others' immunity - understanding gut microbiome in Covid-19.|pdf=|usr=010}}
+
{{tp|p=32582138|t=2020. Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection.|pdf=|usr=011}}
+
{{tp|p=32582134|t=2020. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections.|pdf=|usr=011}}
+
{{tp|p=32574708|t=2020. Mitochondria and Microbiota dysfunction in COVID-19 pathogenesis.|pdf=|usr=010}}
+
{{tp|p=32579301|t=2020. Immunity and protection from COVID-19-Environmental mycobacteria play a role.|pdf=|usr=011}}
+

Version vom 3. August 2020, 20:26 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

012


head
32669777 2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge von Willebrand Factor (eULVWF) Decorated-Platelet Strings.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
32671009 2020. Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37.
C7255426 ?. Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2.
32658591 ?. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
C7236793 ?. Prediction and analysis of key protein structures of 2019-nCoV.
C7341045 2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
C7323676 ?. Coronavirus disease 2019 (COVID-19): cytokine storms hyper-inflammatory phenotypes and acute respiratory distress syndrome.
C7264919 ?. Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains.
32668194 ?. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
32659347 2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.
C7308782 2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.
32683296 2020. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
32669955 2020. A comprehensive investigation of the mRNA and protein level of ACE2 the putative receptor of SARS-CoV-2 in human tissues and blood cells.
C7274027 ?. The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development.
32659712 2020. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.
32707511 2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
32674001 2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis a case series.
32661206 2020. Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human.
C7358169 ?. Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
C7332243 ?. Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection.
C7323226 ?. Cancer Prevales on Covid?19: To Maintain a High Quality Standard Concerning Diagnosis and Oncological Care Even During a Pandemic.
C7351386 ?. Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions.
C7311326 2020. Coronavirus disease 2019?related Kawasaki-like disease in an adult: A case report.
C7314447 ?. Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.
C7296312 ?. Children at risk: multisystem inflammatory syndrome and COVID-19.
C7316659 ?. Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.
C7275990 ?. COVID-19?Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.
32659211 2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
C7292579 2020. Genotyping SARS-CoV-2 through an interactive web application.
C7266609 2020. An integrated national scale SARS-CoV-2 genomic surveillance network.
C7351415 ?. Severe refractory Kawasaki disease in seven infants in the COVID-19 era.
C7259908 2020. Coronavirus is the trigger but the immune response is deadly.
C7234786 2020. Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases.
32680625 2020. Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
C7256601 ?. In Reply?The ?Perfect Cytokine Storm? of COVID-19.
C7256539 2020. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19).
C7256537 ?. THE ?PERFECT CYTOKINE STORM? OF COVID-19.
32721799 2020. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression.
32679425 2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
32679426 2020. The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19?.
32673940 2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
32679424 2020. Natural protection of ocular surface from viral infections ? A hypothesis.
32688183 2020. Corrigendum to ?COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming?? [Med Hypothesis 144 (2020) 109918].
C7326438 2020. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.
C7322475 2020. COVID-19: NAD+ deficiency may predispose the aged obese and type2 diabetics to mortality through its effect on SIRT1 activity.
C7313490 2020. Understanding Covid and the associated post-infectious hyper-inflammatory state (PIMS-TS) in children.
C7313483 2020. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.
32670517 2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.
32670592 2020. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.
C7334952 2020. Pathologic features of COVID-19: A concise review.
32703502 2020. Autopsy of patients with COVID-19: A balance of fear and curiosity.
C7346848 2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
C7328593 2020. Behavioral immune system linked to responses to the threat of COVID-19.
C7329651 ?. Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case report.
C7244417 ?. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach.
32713710 ?. Neuropsychiatric Symptoms in an Adolescent Boy With Multisystem Inflammatory Syndrome in Children.
C7335763 ?. Histopathologische Befunde bei therapierter und nichttherapierter SARS-CoV-2-Infektion ? Bericht über 3 Autopsien.
C7335629 ?. Der erste COVID-19-Hotspot in einer Hamburger Senioreneinrichtung: Präventionskonzept Letalität und Obduktionsbefunde.
C7247437 ?. Evidence for systematic autopsies in COVID-19 positive deceased: Case report of the first German investigated COVID-19 death.
C7311357 2020. Expression profiling meta-analysis of ACE2 and TMPRSS2 the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells and identification of putative modulators.
32702724 ?. Age-dependent assessment of genes involved in cellular senescence telomere and mitochondrial pathways in human lung tissue of smokers COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis .
32702726 ?. SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyper-activation .
32702716 ?. Can Hyperperfusion of Nonaerated Lung Explain COVID-19 Hypoxia? .
32702718 ?. E-cigarette-Induced Pulmonary Inflammation and Dysregulated Repair are Mediated by nAChR ?7 Receptor: Role of nAChR ?7 in ACE2 Covid-19 receptor regulation.
32702714 ?. Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.
32702737 ?. B cell clonal expansion and convergent antibody responses to SARS-CoV-2.
32702728 ?. A potential role for AHR in SARS-CoV-2 pathology.
C7347481 2020. Hemophagocytic syndrome and COVID-19.
C7328624 2020. Sars-CoV-2 et Kawasaki rapprochement ? risque.
C7297549 ?. Kawasaki Disease and Invasive Pneumococcal Infection.
32680648 ?. Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak. head
C7340772 ?. Prototype of a Smart Microfluidic Platform for the Evaluation of SARS-Cov-2 Pathogenesis Along with Estimation of the Effectiveness of Potential Drug Candidates and Antigen?Antibody Interactions in Convalescent Plasma Therapy.
C7358563 2020. Unleashing the mysterious link between COVID-19 and a famous childhood vasculitis: Kawasaki disease.
C7320653 ?. Fractal signature of coronaviruses related to severe acute respiratory syndrome.
C7318729 2020. Gemeinschaftlich in Krisenzeiten: NMR-Strukturbiologie gegen COVID-19.
C7297671 2020. Covid-19: An urgent need for a psychoneuroendocrine perspective.
C7344205 2020. Crystal Structure of the Main Protease of Human Coronavirus NL63.
C7225694 2020. COVID-19 y estudios microbiológicos post mortem.
C7211634 2020. Autopsias en casos sospechosos de SARS-CoV-2.
C7211618 2020. Gestión de los cadáveres durante la pandemia por COVID-19 en España.
C7334659 2020. Devilishly radical NETwork in COVID-19: Oxidative stress neutrophil extracellular traps (NETs) and T cell suppression.
C7292949 2020. NK cells: A double edge sword against SARS-CoV-2.
C7315969 ?. COVID-19 and preeclampsia with severe features at 34-weeks gestation.
32668317 ?. COVID-19?Related Collapsing Glomerulopathy in a Kidney Transplant Recipient.
32659225 ?. The role of a cytokine storm in severe COVID-19 disease in pregnancy.
32659620 2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.
C7314264 ?. Human neutralizing antibodies to SARS-CoV-2: views and perspectives from Professor Linqi Zhang at Tsinghua University.
32718664 ?. Afectación endotelial por COVID-19 en criobiopsia pulmonar.
32682575 ?. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
C7323440 ?. Children s (and autoimmune patients) morbidity (and mortality) from Covid?19 is similar to the general population: immunologic rationale.
C7305885 2020. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
32703419 2020. Proteasome activator PA28?-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
C7356136 2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
32601146 2020. Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.
32665075 ?. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.
C7308744 2020. Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk.
32673567 ?. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32697970 ?. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
32697968 ?. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
C7091918 ?. COVID-19 infection: the perspectives on immune responses.
32735849 ?. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.
32668215 2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
C7276302 2020. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32673668 2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
32673711 2020. mTORC inhibitor Sirolimus deprograms monocytes in ?cytokine storm? in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome.
32659373 2020. Long-term infection of SARS-CoV-2 changed the body s immune status.
C7245680 ?. Hyperinflammation with COVID-19: The key to patient deterioration????.
C7354860 2020. Citrullinated histone H3 a marker of extracellular trap formation is increased in blood of stable asthma patients.
32696004 2020. Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors.
32711241 2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
C7287426 ?. On the evolutionary epidemiology of SARS-CoV-2.
C7328575 ?. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.
C7354376 ?. Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays.
32711184 2020. The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2.
C7335417 ?. Assessment of samples pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia.
32673978 2020. How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory.
32731192 2020. COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic.
C7316051 2020. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.
C7305505 2020. Tocilizumab for treatment of patients with severe COVID?19: A retrospective cohort study.
C7245291 ?. EL CUIDADO HUMANIZADO EN LA MUERTE POR COVID-19: A PROPÓSITO DE UN CASO.
C7357538 ?. Particulate matter (PM10) enhances RNA virus infection through modulation of innate immune responses?.
C7358302 ?. A Study on Herd Immunity of COVID-19 in South Korea: Using a Stochastic Economic-Epidemiological Model.
32665942 2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
C7267447 2020. An address to the European immunology community concerning the Coronavirus pandemic.
C7318732 2020. Can India develop herd immunity against COVID-19?
C7262083 ?. SARS?CoV?2 an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability.
C7337683 ?. Lions Tigers and Kittens too: ACE2 and susceptibility to CoVID-19.
C7337764 ?. COVID-19 and Evolutionary Medicine.
C7324322 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?


32656452 2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
32631771 2020. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.
32598981 2020. Infections and Collapsing Glomerulopathy.
32564928 2020. Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges.
32653819 2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.
32571869 2020. Kawasaki disease or Kawasaki syndrome?
32489438 2020. Spectrum of histopathological findings in coronavirus disease-19, Middle East respiratory syndrome and severe acute respiratory syndrome.
32565134 2020. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
32533513 2020. Cytosolic DNA sensing through cGAS and STING is inactivated by gene mutations in pangolins.
32405132 2020. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury.
32653765 2020. Immunosenescence exacerbates the COVID-19.
32611485 2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32559654 2020. Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling.
32646445 2020. Isolation and characterization of WUPyV in polarized human airway epithelial cells.
32618551 2020. Covid-19 and Kawasaki syndrome.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32645326 2020. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
32649876 2020. Human Virus Transcriptional Regulators.
32623480 2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
32623546 2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
32632255 2020. Pulmonary alveolar regeneration in adult COVID-19 patients.
32612199 2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
32622823 2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
32622819 2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
32118646 2020. Voice from China: nomenclature of the novel coronavirus and related diseases.
32118645 2020. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-novel coronavirus.
32653658 2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.
32533338 2020. A 9-year-old girl with Kawasaki disease and pulmonary nodules.
32418043 2020. Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis.
32513224 2020. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.
32541570 2020. Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 ARDS Patients With Near-Normal Respiratory Compliance.
32642354 2020. Do COVID-19 and SARS Gene Complexities and Variations Help Overcome the Knowledge Gap?
32428465 2020. Pandemics and the great evolutionary mismatch.
32563779 2020. Protective and pathogenic roles for mast cells during viral infections.
32484440 2020. Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells.
32617121 2020. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019.
24935083 2015. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.
23452147 2013. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.
32641214 2020. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.
32637365 2020. Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier.
32655580 2020. Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?
32655579 2020. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.
32612617 2020. The COVID-19 Cytokine Storm; What We Know So Far.
32582219 2020. IL-22 Plays a Critical Role in Maintaining Epithelial Integrity During Pulmonary Infection.
32574256 2020. Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection.
32626680 2020. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study.
32392463 2020. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.
32294404 2020. Something Else to Stress about: Perinatal Stress Attenuates CD8(+) T Cell Activity in Adults.
32500198 2020. Corona deaths in Hamburg, Germany.
32626922 2020. A dissection of SARSCoV2 with clinical implications (Review).
32466119 2020. Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.
32365944 2020. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
32340172 2020. Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway.
32488343 2020. Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients.
32385629 2020. From the quarantine diary of an emergency physician: the coronavirus and the dysautonomic storm.
17340620 2007. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung.
28063205 2017. Pathogenetic determinants in Kawasaki disease: the haematological point of view.
30146782 2019. Modulation of the immune response by Middle East respiratory syndrome coronavirus.
32648027 2020. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
32623351 2020. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates.
16752365 2006. Coronavirus phylogeny based on 2D graphical representation of DNA sequence.
32006540 2020. Genetic diversity and potential recombination between ferret coronaviruses from European and American lineages.
32142930 2020. Insights into the cross-species evolution of 2019 novel coronavirus.
26287378 2016. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.
24760654 2014. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.
32585239 2020. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.
32441751 2020. Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome.
32582339 2020. Variation of 2019 novel coronavirus complete genomes recorded in the 1(st) month of outbreak: Implication for mutation.
32188728 2020. Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
26269185 2015. Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.
24478444 2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
16940539 2006. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein.
32432657 2020. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.
32437764 2020. Visualization of putative coronavirus in kidney.
32505464 2020. Am I a coronavirus?
32653518 2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
32498008 2020. Is the gingival sulcus a potential niche for SARS-Corona virus-2?
32652428 2020. Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?
32634734 2020. Hypoxemia in COVID-19 patients: An hypothesis.
32653475 2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?
32656314 2020. COVID-19-A theory of autoimmunity to ACE-2.
25077179 2014. Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.
32598829 2020. Childhood Multisystem Inflammatory Syndrome - A New Challenge in the Pandemic.
32461612 2020. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.
32555182 2020. Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution.
32651568 2020. T cell renaissance in COVID-19.
32591759 2020. Caught by NETs.
32591758 2020. Transient IgA, steady IgG?
32533112 2020. Neutralizing antibodies in convalescent patients.
32533130 2020. Epigenetic and epitranscriptomic regulation of viral replication.
32561857 2020. Coronavirus replication factories.
32287794 2020. Wuhan-like virus discovered seven years ago.
31863580 2020. A nucleobase-binding pocket in a viral RNA-dependent RNA polymerase contributes to elongation complex stability.
30070073 2018. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease.
28950425 2018. Pulmonary presentation of Kawasaki disease-A diagnostic challenge.
22022266 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
32620366 2020. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
32611518 2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
32650970 2020. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.
32650969 2020. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic.
32434680 2020. AID in Antibody Diversification: There and Back Again.
32651761 2020. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.
28738245 2017. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication.
18045721 2008. SARS coronavirus accessory proteins.
32456011 2020. The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses.
32331321 2020. Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?


32656452 2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
32712145 2020. Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult.
32659225 2020. The role of a cytokine storm in severe COVID-19 disease in pregnancy.
32701539 2020. HLA-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.
32659620 2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.
32653819 2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.
32676824 2020. Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.
32708525 2020. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.
32669265 2020. Discovery of M Protease inhibitors encoded by SARS-CoV-2.
32708430 2020. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.
32653765 2020. Immunosenescence exacerbates the COVID-19.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32717432 2020. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
32685484 2020. Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.
32664932 2020. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
32664879 2020. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
32665075 2020. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.
32708264 2020. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32697970 2020. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
32697968 2020. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
32673567 2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32690996 2020. COVID-19 infection: mitohormetic concept of immune response.
32697943 2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.
32612152 2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.
32623480 2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
32712910 2020. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
32623546 2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
32668215 2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
32632255 2020. Pulmonary alveolar regeneration in adult COVID-19 patients.
32612199 2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32619549 2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
32660065 2020. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
32635598 2020. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.
32707842 2020. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.
32622823 2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
32707182 2020. Novel Temperature Trajectory Subphenotypes in COVID-19.
32622819 2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
32630212 2020. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
32700055 2020. The extended autonomic system, dyshomeostasis, and COVID-19.
32671502 2020. Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis.
32661775 2020. Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna's Autonomic Unit.
32673668 2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
32683814 2020. Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic?
32664709 2020. Immunopathogenesis of COVID-19 and early immunomodulators.
32712394 2020. Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation?
32659373 2020. Long-term infection of SARS-CoV-2 changed the body's immune status.
32653662 2020. Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
32653658 2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.
32717416 2020. Evolution of viral quasispecies during SARS-CoV-2 infection.
32711057 2020. Viable SARS-CoV-2 in various specimens from COVID-19 patients.
32688067 2020. Body temperature and host species preferences of SARS-CoV-2.
32658736 2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.
32709253 2020. Response to "Body temperature correlates with mortality in COVID-19 patients".
32698857 2020. Could the severity of COVID-19 be increased by low gastric acidity?
32690058 2020. Detection of IgG antibody during the follow-up in patients with COVID-19 infection.
32711241 2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
32685628 2020. Haematological and immunological data of Chinese children infected with coronavirus disease 2019.
32707212 2020. Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus.
32665025 2020. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2.
32699547 2020. Kawasaki disease in siblings and a review of drug treatment.
32711256 2020. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.
32711254 2020. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.
32707445 2020. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.
32717182 2020. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
32712315 2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
32707288 2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
32668462 2020. COVID-19: An Immunopathologic Assault.
32709193 2020. Lung Injury in COVID-19-An Emerging Hypothesis.
32673476 2020. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.
32672403 2020. microRNAs as new possible actors in gender disparities of Covid-19 pandemic.
32662161 2020. Covid-19, ACE2, and the kidney.
32681166 2020. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
32666092 2020. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
32662111 2020. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes.
32706609 2020. Inducible Epithelial Resistance Against Coronavirus Pneumonia in Mice.
32663409 2020. Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2.
32662396 2020. Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients.
32705809 2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1.
32716641 2020. Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model.
32686774 2020. Multiple sclerosis and COVID-19.
32654296 2020. A Tale of (Glycogen Synthase Kinase) Three: Lithium, The Kidney and Coronavirus Disease 19.
32679621 2020. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
32678953 2020. Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series.
32678950 2020. Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.
32663362 2020. ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.
32654514 2020. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression.
32689809 2020. Unexpected Features of Cardiac Pathology in COVID-19 Infection.
32706417 2020. Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19.
32717055 2020. Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.
32710613 2020. Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.
32672790 2020. Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.
32667973 2020. SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.
32663256 2020. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.
32694169 2020. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
32713339 2020. Viral Evolution will Automatically Resolve COVID-19 Pandemic.
32660402 2020. NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2.
32657802 2020. Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: menage a trois.
32675718 2020. Reflections on rheumatological aspects of COVID-19.
32654350 2020. Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection.
32662099 2020. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.
32657473 2020. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.
32652001 2020. Endocrine significance of SARS-CoV-2's reliance on ACE2.
32686577 2020. Epigenetic mechanisms regulating COVID-19 infection.
32710612 2020. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.
32643968 2020. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.
32706090 2020. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.
32692465 2020. COVID-19, Cilia, and Smell.
32692408 2020. Third Trimester Placentas of SARS-CoV-2-Positive Women: Histomorphology, including Viral Immunohistochemistry and in Situ Hybridization.
32678695 2020. Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.
32689852 2020. Immune Responses to the Novel Coronavirus-2: Friend or Foe?


32662421 2020. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
32665942 2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
32675207 2020. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.
32675206 2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.
32703822 2020. Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge.
32714336 2020. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.
32676080 2020. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
32695025 2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.
32676039 2020. COVID-19 Sepsis and Microcirculation Dysfunction.
32658591 2020. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
32682765 2020. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19.
32668194 2020. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
32659267 2020. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.
32683337 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.
32683336 2020. Hyperinflammatory Syndrome in Children Associated with COVID-19: Need for Awareness.
32659347 2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.
32708334 2020. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
32668803 2020. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
32664543 2020. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.
32681297 2020. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
32666177 2020. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.
32695405 2020. COVID-19 and cryo-EM.
32675285 2020. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.
32701511 2020. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children.
32708872 2020. Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.
32674356 2020. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.
32690544 2020. Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2.
32707511 2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
32674001 2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
32652214 2020. Factors affecting stability and infectivity of SARS-CoV-2.
32699345 2020. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.
32675312 2020. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.
32652168 2020. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).
32718895 2020. Immune response in COVID-19: A review.
32707537 2020. Hazards of the cytokine storm and cytokine-targeted therapy in COVID-19 patients: A Review.
32627759 2020. An Overview of the Genetic Variations of the SARS-CoV-2 Genomes Isolated in Southeast Asian Countries.
32710986 2020. Mutations Strengthened SARS-CoV-2 Infectivity.
32717229 2020. Epidemiological trends in Kawasaki disease during COVID-19 in Singapore.
32661139 2020. Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
32706339 2020. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
32687484 2020. Severe immunosuppression and not a cytokine storm characterize COVID-19 infections.
32659211 2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
32682491 2020. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
32653054 2020. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
32653518 2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
32693241 2020. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
32687918 2020. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
32703818 2020. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
32694143 2020. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.
32679426 2020. The <> able to explain the Th1 immune lockdown in severe COVID-19.
32679424 2020. Natural protection of ocular surface from viral infections - A hypothesis.
32673940 2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
32683222 2020. The immunomodulatory effects of exercise against COVID-19.
32679425 2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
32664116 2020. Late histological findings in symptomatic COVID-19 patients: A case report.
32670525 2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.
32670517 2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.
32653475 2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?
32710269 2020. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.
32709887 2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.
32709886 2020. Structural basis of RNA cap modification by SARS-CoV-2.
32708840 2020. Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection.
32672799 2020. Eosinopenia and COVID-19.
32680910 2020. Kidney Biopsy Findings in Patients with COVID-19.
32675304 2020. Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19.
32669323 2020. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.
32660970 2020. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.
32651224 2020. Caution in Identifying Coronaviruses by Electron Microscopy.
32700513 2020. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?
32660959 2020. Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva?
32667280 2020. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
32699160 2020. COVID-19: Complement, Coagulation, and Collateral Damage.
32696489 2020. Cytokine storm syndrome in coronavirus disease 2019: A narrative review.
32716059 2020. Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".
32710647 2020. Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.
32706425 2020. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.
32706420 2020. Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.
32706410 2020. SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.
32706407 2020. SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.
32681651 2020. COVID-19: What type of cytokine storm are we dealing with?
32699095 2020. Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
32679087 2020. COVID-19: from rapid genome sequencing to fast decisions.
32654359 2020. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.
32687176 2020. Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design.
32706959 2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
32706954 2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
32678534 2020. Pulmonary Vascular Pathology in Covid-19. Reply.
32678533 2020. Pulmonary Vascular Pathology in Covid-19.
32678532 2020. Pulmonary Vascular Pathology in Covid-19.
32678531 2020. Pulmonary Vascular Pathology in Covid-19.
32719485 2020. Sampling the host response to SARS-CoV-2 in hospitals under siege.
32661393 2020. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.
32704094 2020. LY6E impairs coronavirus fusion and confers immune control of viral disease.
32669681 2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
32717743 2020. Longitudinal analyses reveal immunological misfiring in severe COVID-19.
32668444 2020. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
32659783 2020. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
32661414 2020. A race to determine what drives COVID-19 severity.
32684080 2020. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
32659199 2020. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
32654247 2020. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.
32672025 2020. Immunite cellulaire contre SARS-CoV-2 : substrat de l'immunite croisee entre coronavirus saisonniers et SARS-CoV-2 ?
32686248 2020. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.
32671966 2020. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
32656939 2020. Lessons from dermatology about inflammatory responses in Covid-19.
32668509 2020. Variabilidad genetica y epigenetica, y la pandemia de Covid-19.
32697854 2020. Interferon: the invisible link between COVID-19 and BCGitis female protection?
32697367 2020. inverted question markAre Superantigens the Cause of Cytokine Storm and viral sepsis in Severe COVID-19? Observations and hypothesis.
32680954 2020. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.
32669287 2020. Comprehensive mapping of immune perturbations associated with severe COVID-19.
32651212 2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.


32679910 2020. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.
32678072 2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.
32694615 2020. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.
32715628 2020. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?
32715618 2020. The protein expression profile of ACE2 in human tissues.
32669467 2020. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
32694127 2020. COVID-19 and the Gut Microbiome: More than a Gut Feeling.
32681106 2020. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
32665645 2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
32686754 2020. Antibody responses to SARS-CoV-2 short-lived.
32686753 2020. Virus dissociated from inflammation in fatal COVID-19.
32651570 2020. CRISPRing for host genes regulating SARS-CoV-2.
32651569 2020. SARS-CoV-2 on the neural battleground.
32651568 2020. T cell renaissance in COVID-19.
32690876 2020. Can COVID-19 strike twice?
32699357 2020. COVID-19 management in light of the circadian clock.
32668692 2020. Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.
32691391 2020. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.
32665786 2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
32685291 2020. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.
32659343 2020. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
32671793 2020. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.
32651900 2020. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology.
32611518 2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
32704472 2020. Hemophagocytic syndrome and COVID-19.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
32704018 2020. Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames.
32691370 2020. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.
32702413 2020. Multisystem Inflammatory Syndrome in Children: Is There a Linkage to Kawasaki Disease?
32653566 2020. Understanding The Complex Relationship Between Androgens and SARS-CoV2.
32679691 2020. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.
32666230 2020. Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.
32699972 2020. Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19.
32687861 2020. Phylogenetic and phylodynamic analyses of SARS-CoV-2.
32674515 2020. Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.
32614178 2020. Pulmonary Edema in COVID19-A Neural Hypothesis.
32638079 2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.
32628642 2020. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.
32650004 2020. Eicosanoids: the Overlooked Storm in COVID-19?
32628931 2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32639866 2020. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.
32622243 2020. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.
32611313 2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
32629042 2020. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.
32646930 2020. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.
32645391 2020. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.
32646523 2020. Adrenomedullin in COVID-19 induced endotheliitis.
32643351 2020. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.
32640417 2020. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
32610564 2020. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.
32646736 2020. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.
32650275 2020. Reappearance of effector T cells is associated with recovery from COVID-19.
32629393 2020. Illuminating COVID-19 lung disease through autopsy studies.
32632419 2020. Eosinopenia and COVID-19 patients: So specific ?
32633718 2020. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
32614767 2020. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.
32618497 2020. High neutralizing antibody titer in intensive care unit patients with COVID-19.
32620946 2020. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
32615182 2020. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
32634438 2020. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.
32631841 2020. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.
32631838 2020. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.
32631836 2020. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?
32646049 2020. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.
32646047 2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
32645523 2020. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.
32640274 2020. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.
32641873 2020. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.
32621172 2020. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.
32615316 2020. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
32622082 2020. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
32638151 2020. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.
32634585 2020. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.
32613447 2020. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.
32630032 2020. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.
32629995 2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.
32645951 2020. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.
32640747 2020. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.
32621017 2020. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.
32642784 2020. Serum antibody response in critically ill patients with COVID-19.
32624257 2020. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
32615258 2020. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.
32639084 2020. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
32634129 2020. Kinetics of viral load and antibody response in relation to COVID-19 severity.
32610587 2020. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.
32635302 2020. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.
32645361 2020. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.
32615199 2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.
32622905 2020. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.
32614392 2020. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.
32647285 2020. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.
32645344 2020. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.
32645661 2020. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?
32645660 2020. Is macrophages heterogeneity important in determining COVID-19 lethality?
32650197 2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
32645659 2020. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.
32646911 2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.
32646908 2020. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.
32641700 2020. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
32641705 2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.
32648040 2020. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.
32642842 2020. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.
32627524 2020. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.
32650002 2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32631071 2020. COVID-ARDS Clarified: A Vascular Endotype?
32649217 2020. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.
32608999 2020. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.
32628534 2020. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.
32633104 2020. Covid-19 related IgA vasculitis.
32636189 2020. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.
32643798 2020. Tackling COVID-19 infection through complement-targeted immunotherapy.
32640169 2020. Potential impact of SARS-CoV-2 infection on the thymus.
32641195 2020. Reply to the letter concerning Kawasaki Disease and Covid-19.
32638018 2020. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
32636454 2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
32639942 2020. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
32639941 2020. The early antibody response to SARS-Cov-2 infection.
32638022 2020. Direct evidence of active SARS-CoV-2 replication in the intestine.
32645713 2020. Microbiota and Covid-19. Which came first, the chicken or the egg?
32645228 2020. Angiotensin II Receptors - Impact for COVID-19 Severity.
32631463 2020. COVID-19: Yin and Yang and Herd Immunity.
32645207 2020. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.
32635753 2020. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32614086 2020. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.
32629518 2020. Inflammatory Cell Infiltration of Adrenals in COVID-19.
32643416 2020. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.
32615317 2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
32624498 2020. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.
32643586 2020. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.
32639183 2020. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.
32640487 2020. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.
32644266 2020. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
32644223 2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
32639581 2020. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.
32633840 2020. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).
32633815 2020. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.
32642770 2020. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.
32640066 2020. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.
32641486 2020. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
32622377 2020. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
32611256 2020. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.
32640127 2020. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.
32641847 2020. A COVID-19 model.
32647358 2020. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
32647346 2020. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
32616673 2020. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
32638509 2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.


32611670 2020. Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues.
32627126 2020. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
32641482 2020. LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
32622376 2020. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
32619412 2020. Endothelial cells orchestrate COVID-19 coagulopathy.
32619411 2020. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
32616514 2020. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.
32629204 2020. A hypothesis on the role of the human immune system in covid-19.
32622045 2020. Integrated Approaches to Reveal Mechanisms by which RNA Viruses Reprogram the Cellular Environment.
32616647 2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco.
32616644 2020. Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019.
32620916 2020. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection.
32632085 2020. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
32612128 2020. High-altitude populations need special considerations for COVID-19.
32636479 2020. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
32636475 2020. SARS-CoV-2-specific T cells without antibodies.
32629960 2020. Evidence for SARS-CoV-2 Infection of Animal Hosts.
32640525 2020. Molecular Aspects of COVID-19 Differential Pathogenesis.
32627515 2020. Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.
32638966 2020. Immunological aspects of coronavirus disease during pregnancy: an integrative review.
32621057 2020. The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.
32616709 2020. Mapping the T cell response to COVID-19.
32619819 2020. S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study.
32615987 2020. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis